CURRICULUM VITAE ADRIAN S. WOOLF - Oxford Journals
CURRICULUM VITAE ADRIAN S. WOOLF - Oxford Journals CURRICULUM VITAE ADRIAN S. WOOLF - Oxford Journals
CURRICULUM VITAE ADRIAN S. WOOLF Biomedical Research Centre Professor of Paediatric Science, Updated 17 August 2011 Developmental Biomedicine Research Group, School of Biomedicine, University of Manchester, UK
- Page 2 and 3: 2 1. SELF ASSESSMENT - PERSONAL STA
- Page 4 and 5: 4 1. SELF ASSESSMENT - PERSONAL STA
- Page 6 and 7: 6 3. EDUCATION AND QUALIFICATIONS E
- Page 8 and 9: 8 4. PROFESSIONAL HISTORY House Phy
- Page 10 and 11: 10 Professor of Nephrology (and fro
- Page 12 and 13: 12 5. OTHER APPOINTMENTS AND AFFILI
- Page 14 and 15: 14 7. GRANTS Main peer-reviewed gra
- Page 16 and 17: 16 7. GRANTS (continued) Main peer-
- Page 18 and 19: 18 7. GRANTS (continued) Research T
- Page 20 and 21: 20 Mechanisms of human kidney malfo
- Page 22 and 23: 22 8. LECTURES AT MAJOR NATIONAL AN
- Page 24 and 25: 24 9. ACADEMIC SUPERVISION (continu
- Page 26 and 27: 26 10. TEACHING ACTIVITY Major meet
- Page 28 and 29: 28 12A. PUBLICATIONS - EDITED BOOKS
- Page 30 and 31: 30 12C. PUBLICATIONS - ORIGINAL RES
- Page 32 and 33: 32 31. Loughna S, Yuan HT, Woolf AS
- Page 34 and 35: 34 59. Hillman KA, Johnson TM, Winy
- Page 36 and 37: 36 85. Long DA, Mu W, Price KL, Ron
- Page 38 and 39: 38 109. Mekahli D, Woolf AS, Bocken
- Page 40 and 41: 40 18. Woolf AS, Cale CM. Roles of
- Page 42: 42 42
<strong>CURRICULUM</strong> <strong>VITAE</strong><br />
<strong>ADRIAN</strong> S. <strong>WOOLF</strong><br />
Biomedical Research Centre Professor of Paediatric Science,<br />
Updated 17 August 2011<br />
Developmental Biomedicine Research Group,<br />
School of Biomedicine,<br />
University of Manchester, UK
2<br />
1. SELF ASSESSMENT - PERSONAL STATEMENT<br />
Overview – Main Achievements<br />
● In 2010 I took up a new Chair, Biomedical Research Centre Professor of Paediatric Science<br />
(http://www.medicine.manchester.ac.uk/staff/AdrianWoolf) in the Developmental Biomedicine<br />
Research Group, within the School of Biomedicine in the Faculty of Medical and Human Sciences<br />
at the University of Manchester.<br />
● In 1998 I established an academic Unit for Nephrology and Urology at the UCL Institute of<br />
Child Health, London, UK, which I headed until the end of 2009.<br />
● My research and development work unites Nephrology, Urology, Genetics, Fetal Medicine and<br />
Histopathology clinical services with perspectives from Developmental and Cell Biology and<br />
Molecular Genetics science.<br />
● I have published over 100 original research publications, and over 60 review articles/chapters,<br />
with the main focus on normal and abnormal kidney and urinary tract development.<br />
● According Harzing‟s Publish or Perish web-tool, my „h index‟ is 38, with nine of my publications<br />
having been cited at least 100 times, and 29 others having been cited at least 38 times.<br />
● I have supervised clinical and science students leading to eleven PhD, three MD and two MSc<br />
awarded theses.<br />
● I have been awarded over £4 million through peer-reviewed grants, a figure which excludes<br />
numerous Fellowship awarded to my students.<br />
● From 2006-2009 a clinic at Great Ormond Street Hospital, focusing on kidney and urinary tract<br />
malformations, which has an impact on clinical management and genetic counseling.<br />
● I was a Trustee and Honorary Secretary of The Renal Association (2000-2004)<br />
● I was the Research Secretary of the British Association for Paediatric Nephrology (2000-2002).<br />
● I served on the National Kidney Research Fund (now called Kidney Research UK) grants<br />
committee (1997-2002).<br />
Service delivery<br />
● I have undertaken a Paediatric Nephrology clinic at Great Ormond Street Hospital (1997present),<br />
initially following-up children seen by Professor Martin Barratt.<br />
● In 2006, I established a clinic with Raoul Henenkam, Professor of Clinical Genetics, to make<br />
genetic diagnoses in families with congenital kidney and urinary tract malformations. As of May<br />
2009, we had assessed 86 index cases from 62 families at this special NHS clinic.<br />
Service development<br />
● I established (1997) and chaired a forum for senior academic and clinical Nephrology and<br />
Urology staff to bring together academic and clinical issues.<br />
● I performed two UK-wide surveys (2000) on behalf of the British Society for Paediatric<br />
Nephrology, targeting trainees and Consultants, to establish a „state-of-the-nation‟ picture of<br />
academic training in UK Paediatric Nephrology.<br />
● I took on a newly-formed role (2000-2002), that of academic advisor in annual College<br />
Speciality Advisory Committee assessments of all UK Paediatric Nephrology SpRs.<br />
2
3<br />
1. SELF ASSESSMENT - PERSONAL STATEMENT (continued)<br />
Management<br />
● In 2010 I took up a new Chair, Professor of Paediatric Science at the University of Manchester,<br />
UK, (http://www.medicine.manchester.ac.uk/staff/AdrianWoolf) with a remit to establish a new<br />
research group.<br />
● In 1998 I established an academic Unit for Nephrology and Urology at the UCL Institute of<br />
Child Health, London, UK, which I headed until the end of 2009.<br />
● I forged interactive links between Nephrology, Urology, Clinical Genetics, Fetal Medicine and<br />
Histopathology clinical services, with Developmental Biology and Molecular Genetics science<br />
laboratories.<br />
● My management strategy established an internationally-competitive academic centre for clinical<br />
and laboratory science. Creating an active research and development milieu has positive<br />
implications for clinical services, especially for Paediatric Nephrology and Urology.<br />
● I was Honorary Secretary (2000-2004) to the Renal Association, the main society for all UK<br />
Nephrologists and scientists interested in kidney disease. I was also a Renal Association<br />
Trustee/Director. In these roles, I managed thrice-yearly Executive Committee and Trustee<br />
meetings, twice-yearly Clinical Conferences, the Annual General Meeting and made reports to<br />
Companies House and the Charity Commission.<br />
● I was Research Secretary of the British Association for Paediatric Nephrology (2000-2003),<br />
organising the Annual Research Conference with the Royal College of Paediatrics and Child<br />
Health, also serving at that time on the Executive Committee and acting as Academic Advisor at<br />
College Speciality Advisory Committee assessments for Paediatric Nephrology Specialist<br />
Registrars.<br />
● I was member of National Kidney Research Fund Research Grants Committee (1997-2002).<br />
● From 2002-2007 I was Editor of a new journal, Nephron Experimental Nephrology, and I have<br />
served on the Editorial Boards of Kidney International (2001-2010) and the Journal of the<br />
American Society of Nephrology (2001-2005), the two highest impact factor Nephrology journals.<br />
Teaching<br />
● I spend a considerable amount of time nurturing academic careers of junior clinicians and<br />
scientists, and have supervised 11 PhD, 3 MD and 2 MSc completed theses, several performed<br />
by Paediatric Nephrologists and Urologists.<br />
● Three of my junior staff became Lecturers at University College London, and one of these is<br />
now Reader and was also Head of Learning and Teaching at UCL Institute of Child Health.<br />
Another of my previous students returned to work with me, having been awarded a five year<br />
Senior Fellowship from Kidney Research UK.<br />
● I was Director of the UCL ICH‟s annual Continuing Education in Paediatric Nephrology Week<br />
(1997-2010)<br />
● I chaired Wednesday Lunchtime Clinical Presentations at Great Ormond Street Hospital (2001-<br />
2009), a teaching forum for clinicians and nurses.<br />
● I helped to initiate, and chaired up to 2009, Nephrology „Bipartite‟ meetings which provide a<br />
forum for exchange of clinical cases and research from Great Ormond Street Hospital, and local<br />
Adult Nephrology centres including University College and Royal Free Hospitals.<br />
3
4<br />
1. SELF ASSESSMENT - PERSONAL STATEMENT (continued)<br />
Research<br />
Overview<br />
● My overall aim is to unravel the pathogenesis of kidney and urinary tract malformations, the<br />
commonest causes of childhood end-stage renal failure.<br />
● I have published over 100 original research publications, most on normal and abnormal kidney<br />
and urinary tract development.<br />
● According Harzing‟s Publish or Perish web-tool, my „h index‟ is 38, with nine of my publications<br />
having been cited at least 100 times, and 29 others having been cited at least 38 times.<br />
● I co-edited a book (2003): The Kidney - from Normal Developmental to Congenital Disease.<br />
● I have been awarded over £4 million through peer-reviewed grants, a figure excluding the<br />
numerous Fellowship grants awarded to my students. Major collaborative grants have included<br />
those from the Wellcome Trust and Medical Research Council to establish and analyse a UK<br />
DNA Bank on from families with vesico-ureteric reflux and reflux nephropathy.<br />
Basic mechanisms of renal differentiation.<br />
● I implicated hepatocyte growth factor and glial cell line-derived neurotrophic factor in ureteric<br />
bud morphogenesis.<br />
● I provided evidence for an endogenous origin of renal capillaries.<br />
● I demonstrated that angiopoietins modulate renal capillary morphogenesis.<br />
● I reported that Teashirt-3, a newly-recognised transcription factor, is needed for smooth muscle<br />
differentiation and peristalsis in the ureter.<br />
Animal models of renal disease.<br />
● I am defining the biology of human nephrogenesis genes in animal models, both in vitro (e.g.<br />
organ and cells culture) and in vivo (genetically-engineered mice and in zebrafish).<br />
● I reported that glial cell line-derived neurotrophic factor rescues renal agenesis in a genetic<br />
animal model of human disease.<br />
● I found deregulated expression of angiopoietins in acute tubular necrosis and<br />
glomerulonephritis, and am exploring potential therapeutic effects of these growth factors.<br />
● I demonstrated that renal cyst formation is inhibited by a microtubule-stabilising drug, Taxol,<br />
and that a cell adhesion molecule, galectin-3, modulates cyst growth.<br />
● I demonstrated that urinary flow impairment deregulates gene expression and cell turnover in<br />
fetal kidneys, providing a model for human kidney dysplasia. I also studied a model of posterior<br />
urethral valves to define aberrations of fetal bladder physiology and cell biology.<br />
● I discovered that maternal low protein diet causes apoptotic deletion of nephron precursor cells<br />
accompanied by altered gene expression at the start of kidney development.<br />
Human renal malformations.<br />
● I described imbalanced cell turnover in human dysplastic kidneys, prime examples of disturbed<br />
epithelial/mesenchymal interaction, correlating this with aberrant gene expression of<br />
● I studied human renal dysplastic cells in culture, showing that TGF�1 downregulates<br />
proliferation and induces a pathological epithelial to mesenchymal transformation.<br />
● I published a randomized, prospective trial comparing renal function in medical and surgical<br />
treatment of vesicoureteric reflux, and also a meta-analysis to determine the value of finding<br />
reflux as a predictor of renal damage in children with urine infection.<br />
● In various collaborations, I facilitated discovery of mutations, and/or explored the expression<br />
and roles of genes, in the Kallmann, Bardet-Biedl, renal cysts and diabetes, Fraser, oral facial<br />
digital and Ochoa syndromes, diseases associated with renal agenesis, dysplasia and cystic<br />
disease.<br />
● I also undertake genetic studies in non-syndromic common renal tract malformations such as<br />
vesicoureteric reflux and pelvi-ureteric junction obstruction, and of rarer severe defects such as<br />
non-syndromic kidney dysplasia, posterior urethral valves and persistent cloaca.<br />
4
5<br />
2. PERSONAL DETAILS<br />
Full Name<br />
Adrian Spencer Woolf<br />
Present Post<br />
2010-present<br />
Manchester Biomedical Research Centre Professor of Paediatric Science,<br />
Developmental and Regenerative Medicine Research Group,<br />
School of Biomedicine, Faculty of Medical and Human Sciences,<br />
University of Manchester<br />
Honorary Positions<br />
2010-present<br />
Honorary Consultant in Paediatric Nephrology, Royal Manchester Children‟s Hospital,<br />
Manchester, UK<br />
2010-present<br />
Honorary Professor of University College London, UK<br />
2010-present<br />
Honorary Consultant in Paediatric Nephrology, Great Ormond Street Hospital for Children,<br />
London, UK<br />
Work address<br />
Room D2515, Michael Smith Building, University of Manchester, <strong>Oxford</strong> Road, Manchester,<br />
M13 9PT, UK<br />
Email: adrian.woolf@manchester.ac.uk Telephone: +44 (0)161 275 1534<br />
Website: http://www.medicine.manchester.ac.uk/staff/AdrianWoolf<br />
5
6<br />
3. EDUCATION AND QUALIFICATIONS<br />
Education<br />
1968-1974 St Paul's School, London<br />
1975-1978 Corpus Christi College, Cambridge<br />
1978-1981 Westminster Medical School, London<br />
Qualifications<br />
1981 MB BS, University of London<br />
1982 MA, University of Cambridge<br />
1984 MRCP II UK<br />
1989 MD Thesis, University of London<br />
Courses attended in University College London and Great Ormond Street Hospital London<br />
(from 2003)<br />
● UCL Recruitment Training, 8 September 2003.<br />
● GOSH Appraisal Training for Consultants, 12 September 2003.<br />
● GOSH Moving and Handling Course, September 2003.<br />
● UCL Racial Awareness Training, 3 February 2004.<br />
● GOSH Consultants Update Programme (IT, medicines, risk management and clinical<br />
governance, child protection, postmortem and consent, postgraduate medical education, infection<br />
control and blood transfusion), 17 June 2004.<br />
● GOSH Appraisal Training for Consultants, 28 July 2004.<br />
● GOSH Resuscitation Training Update, Great Ormond Street Hospital, 26 August 2004.<br />
● UCL/Imperial College London Senior Leadership Course, 17-18 January and 2 February 2005<br />
● UCL Good Clinical Practice and the EU Clinical Trials Directive, 7 June 2005.<br />
● UCL New Laws about Contract Obligations, 6 September 2005<br />
● GOSH Consultants Update Programme (Information services, Medicines, Risk management,<br />
Health and safety, Protecting together, Postmortem and consent, Blood transfusion, Infection<br />
control), 6 December 2005.<br />
● GOSH Moving and Handling Course, 12 December 2005.<br />
● UCL Staff Development Reviewer/Reviewee Training Course (Dr SE Tarling) 22 June 2006<br />
● GOSH Consultants Update Day; child protection; data protection and freedom of information;<br />
Health, safety and risk management; Q&A with Chief Executive; Infection control; clinical audit;<br />
fire prevention; waste management; glucometer; medicines management; blood products;<br />
PGMA; Moving and Handling update. 27 March 2007<br />
● UCL Essential HR for Research Managers/Principal Investigators (SB1). 12 June 2007<br />
● London Technology Network - Assertiveness, Influencing, Negotiation & Conflict Handling<br />
Workshop 19 July 2007<br />
● GOSH Resuscitation Update – Great Ormond Street Hospital 16 August 2007<br />
● GOSH Consultant update day. Great Ormond Street Hospital. Counter-fraud, Fires, Moving<br />
and Handling, Medicines, Blood products, Bacteriology, Infection control 24 July 2008.<br />
● Royal Veterinary School. Home Office Module 5. 5-6 February 2009.<br />
● GOSH Resuscitation Update – Great Ormond Street Hospital 28 April 2009<br />
● Royal Veterinary School. Home Office Module 4. 13 May 2009.<br />
● University of Cambridge. Home Office Module 2/3 for Amphibia. 21 July 2009.<br />
● University of Cambridge. Home Office Module 2/3 for Fish. 15 September 2009<br />
6
7<br />
● Royal Veterinary School. Home Office Module 1 and Module 2/3 for Rodents. 19-20 October<br />
2009.<br />
● UCL Diversity in the Workforce Certificate. 2 December 2009<br />
Courses attended in University of Manchester<br />
● University of Manchester. Equality and Diversity Issues MS9. 14 January 2010.<br />
● University of Manchester. Home Office Module 1/2 for rodents (talk-only for update) 19 April<br />
2010 and approval for animal handling 23 April 2010.<br />
● University of Manchester, Faculty of Medical and Human Sciences New Academics<br />
Programme: Induction (6 May 2010); Research Excellence 1 (21 May 2010); Inspirational<br />
Teaching 1 (2 June 2010); Personal Development 1 (23 June 2010); Research Excellence 2 (2<br />
July 2010); Inspirational teaching 2 (14 July 2010); Personal and Professional Development 2<br />
(17 September 2010); Media Training (4 October 2010); Research Ethics Applications (21<br />
October 2010); Examinations and Viva of PhD/MD students (21 February 2011); RE7 21 st<br />
Century Research Profiles (3 March 2011).<br />
● University of Manchester, Recruitment and Selection Module 2 – Shortlisting and Interviewing<br />
for Academic, Experienced staff. 4 June 2010.<br />
● University of Manchester Training to be Academic Advisor (for the University of Manchester<br />
medical course). 8 July 2010.<br />
● Performance Development Review Reviewer Briefing (Academic; TAP5). 8 February 2011.<br />
Courses attended in the Central Manchester Foundation Trust<br />
● CMFT General Induction for staff (HR/Counter fraud/Health and Safety/Customer<br />
care/Information governance/Safeguarding vunerable individuals/Equality and diversity/Fire<br />
safety/Infection control/Responding to risk/Acting in emergencies and major<br />
incident/Organisational development and training. 18 January 2010.<br />
● CMFT Clinic Work Station and Medisec Discharge Notification Forms for Doctors Training<br />
Modules and test. April 2010.<br />
● CMFT Clinical Academic Supervisor Training Level 1 e-Learning Modules on: Introduction to<br />
adult learning principles; Ethics and medical education; Mini-CEX and DOPS; Workplace based<br />
teaching – clinical skill teaching; Workplace based teaching – six step microskill method;<br />
Equality and diversity. 10 and 13 September 2010.<br />
● CMFT eLearning Corporate Mandatory Training Programme Fire Safety Infection Prevention<br />
and Control Customer Care Risk Management Security - Dealing with Violence and Aggression<br />
Safeguarding Vulnerable Individuals Health and Safety Awareness Equality and Diversity. 14<br />
September 2010<br />
● CMFT Informed Consent On the Net – ICON. eLearning Modules 1-21 completed 27<br />
September 2010<br />
● Academic Supervision – Maximising Potential. Half day course. 29 September 2010.<br />
● Manchester Children‟s Hospital Resuscitation Training 25 October 2010<br />
● CMFT Patient Safety Training Day 1 November 2010<br />
● CMFT Mandatory elearning Doctors Corporate Induction Programme; hospital at night; health<br />
and safety awareness; fire safety; risk management; fraud in the NHS; equality and diversity;<br />
customer care; acting in medical emergencies; and major incidents10 November 2010<br />
● CMFT Mandatory Training elearning Consultants Clinical Children's Training Course Infection<br />
Prevention and Control; Safeguarding Adults and Children; Medicines Management; Human<br />
Tissue Act - Introduction/Research/Research Assessment/Human Application/Postmortem;<br />
Early Warning Score; Blood Transfusion; Medical Devices 9 December 2010<br />
● CMFT Good Clinical Practice. Research governance; Applications approvals; Informed<br />
consent; Data management; Safety reporting; Monitoring. 10 January 2011.<br />
● CMFT Mandatory Training Safeguarding Children (level 3). 28 March 2011<br />
7
8<br />
4. PROFESSIONAL HISTORY<br />
House Physician/Surgeon<br />
August 1981 to July 1982 (12 months)<br />
House Physician and House Surgeon, Westminster Hospital, London, UK<br />
Three months in each of the following:<br />
Orthopaedics;<br />
General Surgery;<br />
General Internal Medicine and Cardiology;<br />
General Internal Medicine and Nephrology.<br />
Senior House Officer<br />
August 1982 to July 1984 (24 months)<br />
Senior House Officer at Westminster, Guy's and St Paul's Hospitals, London and Peace<br />
Memorial Hospital, Watford, UK<br />
Six months in each of the following:<br />
General Internal Medicine and Gastroenterology;<br />
General Internal Medicine;<br />
Neurology;<br />
Nephrology (acute and chronic renal failure and renal transplantation)<br />
Registrar<br />
August 1984 to July 1986 (24 months)<br />
Registrar in Medicine, Middlesex Hospital, London, UK<br />
General Internal Medicine with specialist interests in Nephrology (e.g. chronic renal failure),<br />
Calcium Metabolism and Hypertension relating to kidney disease.<br />
Two outpatient clinics/week and 1:5 „on take‟ rota for General Internal Medicine.<br />
August 1986 to June 1988 (23 months)<br />
Research Registrar in Endocrinology, Whittington Hospital, London, UK<br />
MD research on „Atrial Natriuretic Peptide in Renal Disease‟ with studies of patients with<br />
nephrotic syndrome and chronic renal failure<br />
One outpatient clinic/week.<br />
July 1998 (1 month)<br />
Locum Registrar in Nephrology, St Mary‟s Hospital, London, UK<br />
Included all aspects of Acute Nephrology<br />
Senior Registrar<br />
August 1988 - January 1989 (6 months)<br />
Locum Senior Registrar, University College Hospital, London, UK<br />
General Internal Medicine and Nephrology<br />
Two outpatient clinics/week<br />
Care of patients with acute renal failure (e.g. In Intensive Care) and chronic renal failure,<br />
nephrotic syndrome and performed renal biopsies<br />
1:5 „on take‟ rota for General Internal Medicine<br />
8
9<br />
4. PROFESSIONAL HISTORY (continued)<br />
Senior Registrar (continued)<br />
February 1989 to August 1989 (6 months)<br />
Registrar in Nephrology, St Paul's and St Philip's Hospitals, London, UK<br />
Included all aspects of Nephrology including biopsy, transplantation, peritoneal and<br />
haemodialysis.<br />
Two outpatient clinics/week.<br />
September 1989 to September 1991 (25 months)<br />
Research Fellow in Nephrology, Division of Nephrology, University of California in Los Angeles,<br />
USA.<br />
Extensive research experience in Nephrology as well as lecturing on renal physiology and<br />
medicine.<br />
October 1991 to March 1993 (18 months) Honorary Senior Registrar in Medicine, University<br />
College Hospital, London, UK<br />
General Internal Medicine with special interest in Hypertension<br />
Two clinics/week and 1:5 „on take‟ rota for General Internal Medicine<br />
Clinical Senior Lecturer and Honorary Senior Registrar<br />
April 1993 to September 1994 (18 months)<br />
Lecturer in Developmental Biology, Institute of Child Health, London and Honorary Senior<br />
Registrar in Paediatric Nephrology, Great Ormond Street Hospital, London, UK.<br />
Included three months as acting Paediatric Nephrology Registrar (acute and chronic renal failure,<br />
dialysis, renal transplantation)<br />
February 1994 to September 1994 (8 months)<br />
Honorary Registrar, Royal Free Hospital<br />
Undertook 1:5 „on call‟ rota covering the Paediatric Nephrology Unit (acute and chronic renal<br />
failure, dialysis, renal transplantation)<br />
Honorary Consultant<br />
October 1994 to present<br />
Honorary Consultant in Paediatric Nephrology, Great Ormond Street Hospital for Children NHS<br />
Trust, London, UK.<br />
Clinical Senior Lecturer<br />
October 1994 to September 1997<br />
Senior Lecturer in Developmental Biology, Institute of Child Health, London, UK<br />
Reader<br />
October 1997 to September 2000<br />
Reader in Nephrology and Developmental Biology, Institute of Child Health, University College<br />
London, London, UK.<br />
Professor<br />
October 2000 to December 2009<br />
9
10<br />
Professor of Nephrology (and from 1998 Head of the) Nephro-Urology Unit, Institute of Child<br />
Health, University College London, London, UK.<br />
5. OTHER APPOINTMENTS AND AFFILIATIONS<br />
Journal editorial experience<br />
1996-2002 Assistant Editor of Pediatric Nephrology<br />
1996-2001 Associate Editor of Experimental Nephrology<br />
2001-2002 Deputy Editor of Experimental Nephrology<br />
2001-2005 Editorial Board member of Journal of the American Society of Nephrology<br />
2001-2010 Editorial Board member of Kidney International<br />
2002-2007 Editor of Nephron Experimental Nephrology<br />
2005-2007 Member of Faculty of 1000 – Medicine (Nephrology Section)<br />
2005-present Editorial Board member of Journal of Paediatric Urology<br />
2007-present Subject Editor for Paediatric Nephrology in Nephrology Dialysis and<br />
Transplantation<br />
Responsibilities in national societies<br />
2000-2003 Research Secretary of the British Association of Paediatric Nephrology.<br />
2000-2004 Honorary Secretary of The Renal Association, and Trustee/Director of The Renal<br />
Association - this is the major society for all UK Nephrologists and I was the first Paediatric<br />
Nephrologist to hold these positions. I manage thrice-yearly Executive Committee,<br />
Trustees/Directors and Renal Registry Management meetings, twice-yearly Clinical Conferences,<br />
and Annual General Meetings.<br />
2004 Served on Working Party to re-configure Training, Education and Research in The Renal<br />
Association.<br />
2003 Renal Association Working Party for Training, Education and Research<br />
2004 Renal Association/National Kidney Research Fund UK Renal Genetics Group<br />
Member of professional bodies<br />
American Society of Nephrology<br />
Association of Physicians of Great Britain and Ireland<br />
British Association for Pediatric Nephrology<br />
European Society of Paediatric Nephrology<br />
International Society of Nephrology<br />
Royal College of Paediatrics and Child Health<br />
The Renal Association<br />
10
11<br />
5. OTHER APPOINTMENTS AND AFFILIATIONS (continued)<br />
Academic review bodies<br />
● 1996-2002 National Kidney Research Fund project grants and research fellowship committees.<br />
● 2001 INSERM (National French Institute of Health) expert advisor.<br />
● 2006 and 2007 Academy of Finland research grants external committee in Biomedicine.<br />
● I have reviewed grant applications for charities including: Action Research, Biotechnology and<br />
Biosciences Research Council, Dutch Kidney Foundation, Health Research Council of New<br />
Zealand, Kidney Research UK, Medical Research Council, National Kidney Research Fund,<br />
Royal Society, Scottish Hospitals Endowment Research Trust, Wellcome Trust.<br />
● I have reviewed original research articles for the following journals: American Journal of<br />
Pathology, American Journal of Physiology, Anatomy and Embryology, Bioessays, British Journal<br />
of Urology, Development, Developmental Biology, Developmental Genetics, European Journal of<br />
Human Genetics, European Journal of Pediatrics, European Journal of Pediatrics, Experimental<br />
Nephrology, Gene Therapy, Histology and Histopathology, In Vitro, International Journal of<br />
Experimental Pathology, Journal of Anatomy, Journal of the American Society of Nephrology,<br />
Journal of Medical Genetics, Journal of Pediatric Urology, Journal of Physiology, Journal of<br />
Urology, Kidney International, Lancet, Mechanisms of Development-Gene Expression Patterns,<br />
Nature Clinical Practice Nephrology, Nature Genetics, Nature Medicine, Nephrology, Nephron,<br />
Pediatric Nephrology, Pediatric Research, PLoS Biology, Prenatal Diagnosis, Proceedings of the<br />
National Academy of Sciences USA<br />
● Abstract reviewer for National and International Conferences: American Society of Nephrology<br />
(1995, 1997, 1999, 2001, 2010); British Association for Paediatric Nephrology (1997, 2001, 2001,<br />
2003); European Dialysis and Transplant Association (2007); European Kidney Research Forum<br />
(1998); European Society for Pediatric Urology (2010, 2011); International Pediatric Nephrology<br />
Association (1998); The Renal Association (1997, 1999, 2000, 2001, 2002, 2008, 2009, 2010;<br />
2011); World Congress of Nephrology (2009).<br />
Member of scientific organising committees<br />
European Society of Paediatric Nephrology, Helsinki, Finland, 2000; 8th International Workshop<br />
on Developmental Nephrology, Vancouver, Canada, 2001; 9th International Workshop on<br />
Developmental Nephrology, Australia, 2004.<br />
Chaired scientific sessions at national and international conferences<br />
American Society of Nephrology (1997, 2002, 2006); British Association of Paediatric Nephrology<br />
(1997, 2001, 2002); European Kidney Research Forum (1998); Renal Association (1998, 1999,<br />
2000, 2001, 2002, 2003).<br />
University of Manchester<br />
Academic Representative of Child Health on the Council of the Section of Paediatrics,<br />
Manchester Medical Society 2010-2011<br />
11
12<br />
5. OTHER APPOINTMENTS AND AFFILIATIONS (continued)<br />
Invited examiner: PhD/MPhil/MD theses<br />
1998 PhD University of Melbourne, Australia: AT Clarke Studies on the role of transforming<br />
growth factor-�1 and its receptors in kidney development<br />
1998 PhD Chinese University of Hong Kong: TKW Herman Embryonic development of renal<br />
agenesis in a retinoic acid-induced mouse model<br />
1999 PhD Catholic University of Leuven, Belgium: PMA Groenen Genetic studies on renal<br />
malformations<br />
2000 PhD University of Hong Kong, China: LCW Davy RET receptor tyrosine kinase in<br />
developing, adult and polycystic kidneys<br />
2001 PhD. University of Melbourne, Australia: K Moritz Role of the renin-angiotensin system in<br />
the fetal adrenal and kidney during the first half of gestation<br />
2001 PhD University of Cambridge, UK: L Foggensteiner Biology of polycystin1 and polycystin2<br />
2003 PhD Open University, UK: R Case Investigation of the structure and function of the PKD<br />
domain of polycystin-1, the protein product of the PKD gene<br />
2003 PhD. University of Edinburgh, UK: L Michael Specializations at the tips of a branching<br />
epithelium<br />
2003 PhD Aarhus University, Denmark: C Li Dysregulation of renal aquaporins and sodium<br />
transporters in rats with urinary tract obstruction.<br />
2004 PhD. University College Dublin, Ireland: V Dolan Gremlin and induced in high glucose-1:<br />
two diabetic nephropathy associated genes with roles in development.<br />
2004 PhD University of Cambridge, UK: S Mulroy Investigation of a mouse model of autosomal<br />
dominant polycystic kidney disease generated by targeted disruption of the Pkd1 gene.<br />
2004 MD. University of Leeds, UK: J Stahlschmidt Regulation and differentiation in normal and<br />
neoplastic urothelium.<br />
2005 PhD University of Sheffield, UK: L Newby Identification of ligands for the PKD1 protein,<br />
polycystin 1, using genetically modified cells.<br />
2006 PhD Open University, UK (Istituto di Richerche Farmacologiche Mario Negri, Italy): E<br />
Gagliardini Role of nephrin in glomerular permselectivity<br />
2006 PhD Open University, UK (Istituto di Richerche Farmacologiche Mario Negri, Italy): B<br />
Imberti Bone-marrow stem cells to regenerate injured murine renal tissue.<br />
2007 PhD Monash University, Australia: E Mitchell Structural and molecular studies on the<br />
development of the mouse ureter and ureteric tree.<br />
2008 PhD Imperial College London, UK: SK Harten Role of the von Hippel-Lindau tumour<br />
suppressor gene in regulating renal epithelial cell characteristics.<br />
2009 PhD University of Edinburgh, UK; N Lindstrom. Mechanisms of epithelial branching,<br />
nephrogenesis, and the role of the Rho-GTPase family in kidney development.<br />
2009 PhD University of Southern Denmark: K Madsen The renin angiotensin system and kidney<br />
development: novel mechanisms of renin release and angiogenic function of angiotensin II.<br />
2009 PhD University of Aarhus, Denmark; S. Topcu. Renal function in congenital urinary tract<br />
obstruction: the importance of angiotensin II mediated hemodynamic and cellular changes in<br />
response to unilateral neonatal obstruction.<br />
2010 PhD University College London, UK: DH Shukla. Manipulation of the VHL/HIF pathway in<br />
mouse kidney epithelia and pancreatic �-cells.<br />
2011MPhil The Chinese University of Hong Kong, China: W Tang. An investigation of a novel<br />
teratogenic mechanism of retinoic acid by a retinoic acid-induced renal agenesis model.<br />
12
13<br />
6. PRIZES, AWARDS AND OTHER HONOURS<br />
1970 Scholarship, St Paul's School, London<br />
1975 Smyth Scholarship in Natural Sciences, Corpus Christi College, Cambridge<br />
1979 and 1980 Prizes in Surgery, Chemical Pathology and Dermatology, Westminster Medical<br />
School, London<br />
1981 Honours in Medicine, MB BS, University of London<br />
1989 Berkeley Travelling Fellowship, University College Hospital, London<br />
1991 Senior Clinical Training Fellowship, National Kidney Research Fund<br />
1994 Milne-Muehrcke Award, National Kidney Foundation, USA<br />
1996-2002National Kidney Research Fund grants committee<br />
1997 Fellow of the Royal College of Paediatrics and Child Health<br />
1998 Best research presentation prize, 11th International Pediatric Nephrology Association<br />
congress<br />
13
14<br />
7. GRANTS<br />
Main peer-reviewed grants<br />
1989 Berkeley Travelling Fellowship, University College Hospital, London (£10,000). Principal<br />
investigator AS Woolf. Creation of a chimeric kidney.<br />
1991 National Kidney Research Fund Senior Fellowship, 91/2/90 (@£250,000). Principal<br />
investigator AS Woolf. Creation of a genetically engineered mammalian kidney.<br />
1993 Wellcome Trust Project Grant, 037428 (£204,000). Principal investigator LG Fine; coapplicant<br />
AS Woolf. Cell lineage in the developing kidney.<br />
1993 National Kidney Research Fund Project Grant, 92/2/49 (£64,000). Principal investigator AS<br />
Woolf. Generation of cell lines from the H2-K b -tsA58 transgenic mouse.<br />
1993 Central Research Fund, University of London (£2,000). Principal investigator AS Woolf.<br />
Gene expression in human kidney malformations.<br />
1994 British Heart Foundation Project Grant, 94061 (£70,000). Principal investigator AS Woolf.<br />
Vascularisation of the embryonic kidney.<br />
1996 Mainline Research Scheme, University of Hong Kong (£3,000). Principal investigators A<br />
Shum and Gosling; co-applicant AS Woolf. Pathogenesis of the birth defect renal agenesis.<br />
1997 Institute of Child Health Small Project Grant (£10,000). Principal investigator WG van't Hoff;<br />
co-applicants S Haq and AS Woolf. Cloning and characterisation of proximal tubular epithelia<br />
from urine of cystinosis patients.<br />
1996 Wellcome Trust Project Grant, 049506 (£46,000). Principal investigator AS Woolf. Kidney<br />
cell lineage.<br />
1996 British Heart Foundation Project Grant, 96120 (£92,000). Principal investigator AS Woolf.<br />
Vascularisation of the embryonic kidney.<br />
1996 National Kidney Research Fund Project Grant, R11/2/96 (£65,000). Principal investigator<br />
AS Woolf; co-applicants MA Hanson, P Mouriquand and P Foxall. Cell biology of obstruction of<br />
the fetal sheep kidney.<br />
1997 Action Research Project Grant, S/P/3178 (£76,380). Principal investigator AS Woolf; coapplicant<br />
PJD Winyard. Cell biology of human multicystic dysplastic kidney malformations.<br />
1998 National Kidney Research Fund Project Grant R34/1/98 (£75,000). Principal investigator S<br />
Malcolm; coapplicants AS Woolf and SA Feather. Genetics of human primary vesicoureteric<br />
reflux and its associated nephropathy.<br />
1998 National Kidney Research Fund Research Studentship. S10/98 (£36,000). Principal<br />
investigators AS Woolf and PJD Winyard. Galectin-3 and renal tubular morphogenesis.<br />
1999 Wellcome Trust Project Grant 058005 (£102,799). Principal investigator AS Woolf.<br />
Angiopoietins and the Tie-2 receptor in renal endothelial development.<br />
14
15<br />
7. GRANTS (continued)<br />
Main peer-reviewed grants (continued)<br />
1999 National Kidney Research Fund Project Grant R3/2/99 (£31,400). Principal applicant AS<br />
Woolf; co-applicant PJD Winyard. Does galectin-3 modulate cyst formation in the cpk model of<br />
autosomal recessive polycystic kidney disease?<br />
1999 Medical Research Council Research PhD Studentship (£36,000). Principal investigators AS<br />
Woolf and DA Long. Growth factors and the kidney vasculature.<br />
2000 National Kidney Research Fund Project Grant R11/1/2000 (£74,838). Principal investigator<br />
SA Feather; co-applicants AS Woolf and S Malcolm. The search for the gene responsible for<br />
vesicoureteric reflux and reflux nephropathy on chromosome 1.<br />
2000 National Kidney Research Fund Project Grant R18/1/2000 (£73,592). Principal investigator<br />
PJD Winyard; co-applicant AS Woolf. Roles of urinary tract obstruction, PAX2 and transforming<br />
growth factor �1 in the pathogenesis of human dysplastic kidneys.<br />
2000 National Kidney Research Fund Research PhD Studentship ST1/2000 (£40,000).<br />
Application by AS Woolf and S Malcolm.<br />
2001 Action Research Project Grant (£125,000) Principal investigator SA Feather; co-applicants<br />
S Malcolm and AS Woolf. Genetics and biology of the oral facial digital syndrome type 1:<br />
relevance to normal development and polycystic kidney disease.<br />
2001 National Kidney Research Fund Project Grant R16/1/2001 (£46,156) Principal investigator<br />
AS Woolf; co-applicant A Wade. Effects of low protein diets on early nephrogenesis.<br />
2001 National Kidney Research Fund Project Grant R4/2/2001 (£96,672) Principal investigator<br />
AS Woolf; coapplicant HT Yuan. Angiopoietin-2 and kidney vascular development.<br />
2002 National Kidney Research Fund Studentship ST3/2002 (£50,000). Application by AS Woolf<br />
and PJD Winyard.<br />
2002 Medical Research Council Research PhD Studentship G78/7766 (£40,000). Theme<br />
studentship awarded to D Jenkins with AS Woolf primary supervisor. The genetics and<br />
developmental biology of vesicoureteric reflux<br />
2002 Wellcome Trust Functional Genomics Programme Grant (total £270,000 of which £170,000<br />
to AS Woolf) Principal investigaotors AS Woolf and THJ Goodship; coapplicants S Malcolm, SA<br />
Feather and JA Goodship. Vesicoureteric reflux in the United Kingdom – establishing a DNA<br />
collection for affected families. 01NU29<br />
2003 Kidney Research Aid Fund project grant (£104,218) Coapplicants-coinvestigators Principal<br />
investigaotor AS Woolf; coapplicants M Bitner-Glindzicz, DT Wilcox, SM Whitten and D Jenkins.<br />
Genetics of malformations of the human kidney and lower urinary tract.<br />
2003 Kidney Research Aid Fund project grant (£62,658) Principal applicant MK Farrugia;<br />
coapplicants AS Woolf and PM Cuckow. A model with which to understand the basis of fetal<br />
urinary bladder outflow obstruction.<br />
2004 Kidney Research Aid Fund Project Grant. (£34,717) Principal investigator MK Farrugia; coapplicants<br />
AS Woolf and PM Cuckow. A model with which to understand the urodynamics of fetal<br />
bladder outlet obstruction.<br />
15
16<br />
7. GRANTS (continued)<br />
Main peer-reviewed grants (continued)<br />
2004 Biotechnology and Biological Sciences Research Council. PhD Studentship. S04/G163<br />
(£37,500) Principal investigator AS Woolf; co-applicant H Skaer. Genetic regulation of<br />
mesenchymal-epithelial precursor cell transformations in mammalian and fly kidneys.<br />
2004 Wellcome Trust Project Grant. 073624 (£198,796) Principal investigators AS Woolf and PJ<br />
Scambler. Defining roles for Fras1, a Fraser syndrome gene, in mouse metanephrogenesis.<br />
2004 National Kidney Research Fund Start-Up Grant RP20/1/2004 (£30,000). Principal applicant<br />
J Southgate; co-applicants AS Woolf, D Jenkins, M Bitner-Glindzicz and SA Feather. Functional<br />
analyses of uroplakin gene mutations; implications for differentiation of the urinary tract.<br />
2004 Wellcome Trust Project Grant. 075311 (£226,547) Principal investigator AS Woolf; coapplicants<br />
AM Fry and SA Feather. OFD1, a centrosomal protein mutated in human polycystic<br />
kidney disease: an investigation of its role in kidney growth and differentiation’.<br />
2005 Kidney Research Aid Fund/Kids Kidney Appeal Project Grant (£62,676). Co-applicant DA<br />
Long. Angiopoietin as a therapy for acute renal disease<br />
2005 National Kidney Research Fund PhD Studentship ST1/2005 (£50,084). Principal applicant<br />
AS Woolf,. A study of candidate molecules which modulate dietary programming of early<br />
nephrogenesis.<br />
2005 Kidney Research Aid Fund/Kids Kidney Appeal Project Grant (£54,144). Principal applicant<br />
Dr S Marks; co-applicants Dr K Tullus, Ms E Brennan, Professor AS Woolf. Childhood renal<br />
artery stenosis: a familial study and establishment of a DNA bank.04NU33.<br />
2006 Medical Research Council (£547,276: £25,000 direct allocation to UCL ICH via Newcastleupon-Tyne<br />
Medical School). G0600040. SNP based sib-pair linkage study to identify loci<br />
contributing to vesicoureteric reflux and its associated nephropathy. Principal applicant JA<br />
Goodship; co-applicants HJ Cordell, TH Goodship, SA Feather, RB Kenda and AS Woolf.<br />
05NU10.<br />
2006 Kids Kidney Research (£85,940) Exploring how vascular endothelial growth factor<br />
enhances the growth and differentiation of the embryonic urinary bladder. Principal applicant AS<br />
Woolf; co-applicant DA Long. 06NU10<br />
2007 British Council (£2,100) Investigating the roles of Teashirt transcription factors in the<br />
developing and injured/regenerating mouse renal system. Principal applicant Professor AS<br />
Woolf; co-applicant Ms C Gannon.<br />
2007 Kids Kidney Research (£29,510). Roles for Tbx1 in normal and abnormal renal tract<br />
morphogenesis ? Principal applicant Professor AS Woolf; co-applicants Professor PJ Scambler<br />
and Dr JE Pitera. 07NU04.<br />
2008 Wellcome Trust (£301,577) Roles for Fras1, a basement membrane-associated protein, in<br />
normal differentiation of kidney collecting ducts and glomeruli. Principal applicant Professor AS<br />
Woolf; co-applicants Professor PJ Scambler and Dr JE Pitera 07NU27/085077/Z/08/Z.<br />
2008 Kidney Research UK (£56,421) Gene profiling in renal agenesis. Principal applicant<br />
Professor AS Woolf; co-applicants Professor PJ Scambler and Dr JE Pitera. 08NU07-RP35/2008<br />
16
17<br />
7. GRANTS (continued)<br />
Main peer-reviewed grants (continued)<br />
2008 Diabetes UK (£249,902) The role of angiopoietin growth factors in diabetic nephropathy.<br />
Principal applicant Dr L Gnudi (King‟s College London), co-applicants Dr DA Long and Professor<br />
AS Woolf. 08NU19.<br />
2009 Kids Kidney Research (£99,150) Targeting blood vessels to prevent polycystic kidney<br />
disease. Principal investigator Dr DA Long, co-applicants Dr PJ Winyard and Professor AS<br />
Woolf.<br />
2009 Kids Kidney Research (£70,100) Comprehensive genetic screening of patients with renal<br />
malformations: a pilot study. Principal investigator Dr D Bockenhauer, co-applicants Professor<br />
Klata (Royal Free Hospital), Professor AS Woolf and Dr S Adalat.<br />
2010 Kids Kidney Research (£99,633) Defining kidney expression of Teashirt genes in health,<br />
injury and regeneration. Principal investigator Professor AS Woolf.<br />
2010 Kidney Research UK (£179,587) Uro-facial syndrome (UFS): a novel genetic model to<br />
understand human renal tract function and malformation. Principal investigator Dr William G.<br />
Newman, co-applicants Professor AS Woolf, Dr E McKenzie and Dr E Hilton.<br />
2011 BBSRC Research Council DTG PhD Studentships 2011/12 Faculty of Medical and Human<br />
Sciences (£76,337) The renal glomerulus as a model of extracellular matrix production in<br />
differentiation and normal ageing. Principal applicant Dr R Lennon; co-applicant Professor AS<br />
Woolf<br />
2011 Kids Kidney Research PhD Studentship (£99,226) Proteomic analyses of kidney glomerular<br />
extracellular matrix in health and disease Principal applicant Dr R Lennon; co-applicant Professor<br />
AS Woolf.<br />
2011 Kidney Research UK (£99,944) Restoring the angiopoietin balance as a therapy for<br />
glomerular disease. Principal applicant Dr DA Long; co-applicants Professor AS Woolf and<br />
Professor L Gnudi<br />
17
18<br />
7. GRANTS (continued)<br />
Research Training Fellowships and Studentships awarded to members of Professor<br />
Woolf's research group<br />
Paula R Towers. 1993 Medical Research Council Studentship (£40,000) The RET receptor and<br />
kidney development<br />
Paul JD Winyard. 1994 Action Research Training Fellowship (£110,000) Biology of Kallmann's<br />
syndrome; and 1997 Institute of Child Health and Great Ormond Street Hospital Lectureship in<br />
Paediatric Clinical Science (four years salary)<br />
Catherine M Cale. 1995 Action Research Training Fellowship (£80,000) Inflammatory mediators<br />
in renal development<br />
Sally A Feather. 1996 Action Research Training Fellowship (£110,000) Genetics of renal<br />
malformations; and 1999 Institute of Child Health and Great Ormond Street Hospital Lectureship<br />
in Paediatric Clinical Science (four years salary)<br />
MR (Shuman) Haq. 1998 Great Ormond Street Hospital and Institute of Child Health Science<br />
Development Initiative Research Training Fellowship (£107,000) Cloning and characterisation of<br />
proximal tubular epithelia from urine of cystinosis patients<br />
Naima Smeulders. 2000 Action Research Training Fellowship (£100,000) Effects of stretch on the<br />
cell biology of the developing bladder<br />
Nikesh Thiruchelvam. 2001 Royal College of Surgeons of England Research Training Fellowship<br />
(£40,000) Effects of in utero outflow obstruction on the developing urinary bladder<br />
Liam SL McCarthy. 2002 Institute of Child Health, London, Springboard Fellowship (£130,000)<br />
Integrins in detrusor development<br />
Larissa Kerecuk. 2007 Medical Research Council Clinical Training Fellowship. FIS ref 11707<br />
(£147,263) Exploring the expression and potential roles of Fras1 and Frem2 in models of kidney<br />
diseases affecting the collecting duct lineage. 06NU12<br />
Michiel Schreuder. 2008 European Renal Association (@£25,000) Modelling fetal kidney<br />
programming ex vivo<br />
David A Long. 2008 Kidney Research UK Senior Non-Clinical Fellowship. (£319,578) Roles of<br />
angiopoietins in epithelial-endothelial interactions: using the renal glomerulus as a model system.<br />
Shazia Adalat. 2009 NIHR via ICH/GOSH Biomedical Research Centre Clinical Research<br />
Associate Fellowship (£157,598). The genetic basis of human non-syndromic renal tract<br />
malformations. 08NU18.<br />
18
19<br />
8. LECTURES AT MAJOR NATIONAL AND INTERNATIONAL MEETINGS<br />
Can we cure kidney malformations? British Paediatric Association, Warwick, UK, 1994<br />
Therapies for polycystic kidney diseases, 3 rd European Polycystic Kidney Workshop, Leiden,<br />
Netherlands, 1994<br />
Biology of kidney malformations. 10 th Congress of the International Paediatric Nephrology<br />
Association, Santiago, Chile, 1995<br />
Kidney malformations - what goes wrong and why it goes wrong. Renal Association, London,<br />
UK, 1995<br />
Renal genesis and dysgenesis. National Kidney Foundation, New York, USA, 1995<br />
Dysplastic kidneys. European Society for Paediatric Urology, London, UK, 1996<br />
Dysplastic kidneys - immature or just plain mixed up? British Paediatric Association, York, UK,<br />
1996<br />
Relevance of kidney development to practice of nephrology. Royal Society of Medicine, London,<br />
UK, 1996<br />
Hepatocyte growth factor/met and mesenchyme/epithelial interactions. American Society of<br />
Nephrology, New Orleans, USA, 1996<br />
Mesenchymal-epithelial induction. American Society of Nephrology Advances in Basic Science<br />
Conference, New Orleans, USA, 1996<br />
Biology of renal malformations. German Speaking Society for Paediatric Nephrology, Zurich,<br />
Switzerland, 1997<br />
Cytokines and renal differentiation. 14 th International Congress of Nephrology, Sydney,<br />
Australia, 1997<br />
Normal kidney development and mistakes that lead to congenital nephropathies. XXIVth<br />
Congress of European Dialysis and Transplant Association, Geneva, Switzerland, 1997<br />
Receptor tyrosine kinases in epithelial and endothelial differentiation in the metanephros. Stem<br />
Cell Growth and Manipulation Symposium, Wuerzburg, Germany, 1997<br />
The enigma of human kidney malformations. Festschrift for Prof TM Barratt, London, UK, 1997<br />
Kidney development. Advanced Neonatology course, Queen Charlotte's and Chelsea Hospital,<br />
London, UK. 1998<br />
Mechanisms of human kidney malformations. Developmental Pathology Society, Canterbury,<br />
UK, 1998.<br />
Advances in the cellular and molecular biology of kidney malformations. Genes, Embryos and<br />
Birth Defects, London, UK. 1998<br />
The development of the kidney. 2 nd UK Nephrology Summer School, London, UK, 1998<br />
Renal endothelial differentiation and Tie receptor tyrosine kinase signalling. 7 th International<br />
Workshop on Developmental Biology, Stockholm, Sweden, 1998.<br />
Cell culture and communication - the origins of kidney epithelia and endothelial cells. 11 th<br />
Congress of the International Pediatric Nephrology Association, London, UK, 1998.<br />
Molecular bases of kidney malformations. 3 rd Meeting of Pediatric Nephrology, Verona, Italy,<br />
1998.<br />
Molecular and morphological bases of renal development. 13 th INSERM Seminar in<br />
Fundamental Nephrology, Paris, France, 1998.<br />
Molecular lesions in human renal malformations. Princess Liliane Symposium, Brussels,<br />
Belgium, 1998<br />
Genetics of reflux nephropathy and renal dysplasia Renal Association Advanced Nephrology<br />
Course, London, UK, 1999.<br />
Reflux nephropathy. Advanced Medicine Conference, Royal College of Physicians, London, UK,<br />
1999.<br />
Tie receptors and renal endothelial development. Mount Sinai and Albert Einstein Schools of<br />
Medicine, New York, USA, 1999<br />
Development of normal and cystic renal epithelia. 15 th International Society of Nephrology,<br />
Buenos Aires, Argentina, 1999<br />
19
20<br />
Mechanisms of human kidney malformations. Necker Seminar in Nephrology, Paris, France,<br />
1999.<br />
8. LECTURES AT MAJOR NATIONAL AND INTERNATIONAL MEETINGS (continued)<br />
Fetal development and renal function. Rank Prize Funds Symposium on Nutrition and the<br />
Kidney, Lake District, UK, 1999<br />
Human renal malformations. 7 th Leicester Paediatric Nephro-Urology Symposium, Leicester,<br />
UK, 1999<br />
Mouse models of renal diseases. International Symposium in Mouse Pathology, Helsinki,<br />
Finland, 1999<br />
Genes which regulate the development of the kidney and urinary tract. 36 th Congress of<br />
European Dialysis and Transplant Association, Madrid, Spain 1999<br />
Tie receptor tyrosine kinases and kidney vessel development. American Society of Nephrology<br />
Basic Science Symposium, Miami, USA, 1999.<br />
Mechanisms of kidney organogenesis and Mouse models of human kidney malformations. 1 st<br />
Developmental Biology and Dysmorphology Course, European Genetics Foundation, Sestri<br />
Levate, Italy, 1999.<br />
Is there a genetic basis for vesicoureteric reflux and its nephropathy? 34 th European Society of<br />
Paediatric Nephrology, Helsinki, Finland, 2000.<br />
The life of the human kidney before birth. 50 th Meeting Renal Association, Cambridge, UK,<br />
2000.<br />
Cell turnover in normal and abnormal kidney development. 3 rd Japanese-European Nephrology<br />
Forum: Developmental Nephrology and Renal Engineering, Tokyo, Japan 2001.<br />
Renal vascular differentiation in health and disease. European Society of Paediatric Urology,<br />
Aarhus, Denmark, 2001.<br />
Dysplastic kidneys – Immature or just mixed-up? 8 th International Workshop on Developmental<br />
Nephrology, Victoria, British Colombia, Canada, 2001.<br />
Advances in genetics and treatment of primary vesicoureteric reflux and its associated<br />
nephropathies. 12 th International Paediatric Nephrology Association congress. Seattle, USA,<br />
2001.<br />
The basis of fetal obstructive nephropathy. Congress of the Italian Society of Paediatric<br />
Nephrology and Paediatric Urology, Rome, Italy, 2001.<br />
Reflux nephropathy. Renal Association Advanced Nephrology course, London, UK, 2002.<br />
Vesicoureteric reflux and associated nephropathies: advances in genetics and surgery. Royal<br />
Society of Medicine, Paediatric Section, London, UK, 2002.<br />
Genetic bases of congenital uropathies and nephropathies. Arbeitsgemeinschaft fur<br />
Padiatrische Nephrologie, Essen, Germany, 2002.<br />
Genetics of vesicoureteric reflux and renal dysplasia. Royal Society of Medicine, Nephrology<br />
and Urology Section, Section, Birmingham, UK, 2002.<br />
Effect of maternal diet on the biology of very early kidney development. 34th Congress of the<br />
European Renal Association and the European Dialysis and Transplant Association,<br />
Copenhagen, Denmark, 2002.<br />
Apoptotic death in congenital kidney disease. World Congress of Nephrology, Berlin, Germany,<br />
2003.<br />
Cell suicide as a common mechanism of diverse kidney malformations. 5 th World Congress on<br />
Urological Research, London, UK.<br />
A molecular and genetic view of human renal and urinary tract malformations. American Society<br />
of Nephrology, San Diego, 2003.<br />
Maternal diet affects embryonic kidney gene expression. 5 th Japan-Europe Nephrology Forum,<br />
Hakone, Japan.<br />
Role of hypoxia and angiogenesis in renal disease. 36 th Congress of the European Renal<br />
Association and the European Dialysis and Transplant Association, Lisbon, Portugal, 2004.<br />
Initiation of the Renal Vasculature. Symposium on New Paradigms in Vascular Biology: Renal<br />
Implications, American Society of Nephrology, St Louis, 2004<br />
20
21<br />
Manipulating kidney differentiation. Kidney International Nephrology Forum, The Renal<br />
Association. Belfast. 2005.<br />
8. LECTURES AT MAJOR NATIONAL AND INTERNATIONAL MEETINGS (continued)<br />
Molecular and genetic analyses of renal capillary development. International Society of<br />
Nephrology, Forefront in Nephrology, Symposium on Stem Cell and Regeneration of the Kidney.<br />
Karuizawa, Japan, 2005.<br />
Future perspectives in genetics of paediatric urology. European Society for Pediatric<br />
Urology/American Academy of Pediatrics. Uppsala, Sweden. 2005.<br />
Understanding vesicoureteric reflux and associated nephropathies. Paediatric Nephrology for<br />
the General Paediatrician. ICH Institute of Child Health London, UK. 2005.<br />
Fraser syndrome, FRAS1 and metanephric development. American Society of Nephrology,<br />
Philadelphia, USA. 2005.<br />
FRAS/FREM gene mutations cause human and mouse Fraser syndromes and lead to early<br />
death of the metanephros. EuReGene Symposium on Renal Development, Berlin, Germany.<br />
2006.<br />
Teratogens, maternal environment and fetal kidney growth. Continuing Education Programme in<br />
Paediatric Nephrology and Urology, UCL Institute of Child Health London, UK. 2006.<br />
FRAS and FREM gene mutations cause human and mouse Fraser syndromes and lead to a<br />
range of renal malformations. Fourth Course on Genetics and Renal Diseases, Genova, Italy.<br />
2006.<br />
Human renal tract malformations: unraveling the genes. XLIII Congress European Renal<br />
Association and the European Dialysis and Transplant Association, Glasgow, UK. 2006.<br />
Orchestrating kidney development: messages from the clinic. XLIV Congress European Renal<br />
Association and the European Dialysis and Transplant Association, Barcelona, Spain. 2007<br />
Developmental biology of renal tract malformations: lessons for Paediatricians. The Catherine<br />
Chisolm Lecture at the Manchester Medical Society, Manchester, UK. 2007.<br />
Human renal dysplasia syndromes: mixing cell biology and genetics. XLV European Renal<br />
Association- European Dialysis and Transplant Association Congress, Stockholm, Sweden.<br />
2008.<br />
Uroplakins: key players in renal tract development. British Renal Society/Renal Association<br />
joint conference, Glasgow, UK. 2008.<br />
New molecular players in the biology of urinary tract malformations. Plenary lecture.<br />
European Society for Paediatric Nephrology, Lyon, France, 2008.<br />
Transition to adult care for children with renal tract malformations. Royal College of Physicians<br />
of Edinburgh, Edinburgh, UK, 2008.<br />
Renal involvement in patients with hepatocyte nuclear factor-1B mutations. Spanish Society of<br />
Nephrology, San Sebastian, Spain 2008.<br />
Ureter development – mouse models. Rayne Foundation, Course in Pediatric Urology, Shaare<br />
Zedek Medical Center, Jerusalem, Israel, 2008.<br />
Genetics and counseling in congenital urinary anomalies. Rayne Foundation, Course in Pediatric<br />
Urology Shaare Zedek Medical Center, Jerusalem, Israel, 2008.<br />
Congenital kidney malformations: don’t forget the ureter. World Congress of Nephrology, Milan,<br />
Italy, 2009.<br />
Development of the renal-urogenital system. 5 th International Course on Genetics and Renal<br />
Disease, Genova, Italy, 2009.<br />
Vesicoureteric reflux and genetics. International conference on vesicoureteral reflux in children.<br />
Goteborg, Sweden, 2009.<br />
Genes which control morphogenesis and functional maturation of the mammalian ureter.<br />
KIDSTEM International Conference. Edinburgh, UK, 2009.<br />
Smooth Muscle Dysplasia of the Ureter. NIH Symposium on Renal Tract Malformations.<br />
Washington DC, USA, 2009.<br />
21
22<br />
8. LECTURES AT MAJOR NATIONAL AND INTERNATIONAL MEETINGS (continued)<br />
Reflux Nephropathy and other developmental disorders of the renal tract. The Renal Association<br />
60 th Anniversary Symposium. Manchester, UK, 2010.<br />
Fetal programming: from gene to function. American Society of Nephrology, Denver, USA,<br />
2010.<br />
Genetics of renal agenesis and dysplasia. 2 nd Joint Meeting of the The Renal Association and<br />
Société de Néphrologie: Entente Cordiale. Paris, France, 2011<br />
Fetal programming of polycystic kidneys ADPKD in Europe: clinical and experimental research”<br />
Berlin, Germany, 2011.<br />
Environmental influences on renal tract development. Padriatrietag, Bamberg, Germany, 2011.<br />
Matrix molecules and human renal malformations: the Fraser and Ochoa syndromes. First AMG<br />
Genetic Symposium on the Genetics of Ciliopathies and Renal Diseases, Utrecht, The<br />
Netherlands.<br />
To be presented<br />
Human kidney malformations: lessons from two renal-genetics clinics. 44th Annual ESPN<br />
Meeting, Dubrovnik, Croatia, 14 - 17 September 2011.<br />
22
23<br />
9. ACADEMIC SUPERVISION<br />
* indicates AS Woolf was primary supervisor<br />
PhD Theses completed and awarded with subsequent appointments<br />
* Maria Kolatsi-Joannou (1993-1996) University of London PhD awarded 1996: Hepatocyte<br />
growth factor/scatter factor and renal morphogenesis. 1996 Appointed as postdoctoral research<br />
assistant, Neural Development Unit, UCL Institute of Child Health.<br />
* Paula R Towers (1993-1997) University of London PhD awarded 1998: The role of glial cell linederived<br />
neurotrophic factor signalling pathway in mammalian organogenesis. 1997 Appointed as<br />
postdoctoral research assistant, National Institute of Medical Research, London.<br />
* Paul JD Winyard (1993-1997) University of London PhD awarded 1998: The biology of kidney<br />
malformations. 1997 Appointed as Lecturer in Paediatric Clinical Science. Currently, Senior<br />
Lecturer and Head of Learning and Teaching, UCL Insititute of Child Health.<br />
* Catherine M Cale (1995-1998; cosupervisors Dr G Morgan and Dr N Klein). University of<br />
London PhD awarded 1998: Inflammatory mediators and abnormal renal development. 1998<br />
Appointed Specialist Registrar in Immunology. Currently, Consultant in Immunology at Great<br />
Ormond Street Hospital.<br />
Sally A Feather (1996-1999; cosupervisor Professor S Malcolm). University of London PhD<br />
awarded 1999: Genetics of renal malformations. Subsequently, Lecturer in Paediatric Clinical<br />
Science, UCL Institute of Child Health. Currently, Consultant in Paediatric Nephrology, St<br />
James‟s University Hospital, Leeds.<br />
Tanya Johnson (1998-2001; cosupervisor Dr PJD Winyard) University of London PhD awarded<br />
2001: The biology of galectin-3 in normal and cystic renal development. 2001 She was awarded<br />
UCL Bogue Travelling Fellowship to study at Columbia University, New York, USA. 2002<br />
Research manager Glaxo-Wellcome.<br />
* David A Long (1999-2003; cosupervisor Dr HT Yuan) University of London PhD awarded 2003:<br />
Growth factors and the kidney vasculature. Subseqeuntly UCL Bogue Travelling Fellow,<br />
Universities of Houston and Gainesville. Currently, Kidney Research UK Senior Fellow at the<br />
Nephro-Urology Unit, UCL Institute of Child Health<br />
* Dagan Jenkins (2002-2005; cosupervisors Dr Bitner-Glindzicz, Professor S Malcolm and Dr SA<br />
Feather) PhD: Genetics of human renal tract malformations. 2005 Postdoctroral fellow,<br />
Weatherall Institute of Molecular Medicine, University of <strong>Oxford</strong>, UK.<br />
* Liam S McCarthy (2001-2004; primary supervisor after Mr DT Wilcox moved to USA) PhD:<br />
Extracellular matrix biology in normal and abnormal bladder development. Currently, Consultant<br />
in Paediatric Urology, Birmingham Children‟s Hospital.<br />
Miliyun Chiu (2003-2006; cosupervisor Dr PJD Winyard) PhD: Galectin-3 and the development<br />
of autosomal recessive polycystic kidney disease. Subsequently, Management Consultant trainee<br />
in the City of London.<br />
* Claire M Lye (nee Gannon) (2004-2007; cosupervisors Dr H Skaer and Prof PJ Scambler) PhD:<br />
Teashirts in the mammalian urinary tract. Subsequently, postdoctoral scientist, University of<br />
Cambridge.<br />
23
24<br />
9. ACADEMIC SUPERVISION (continued)<br />
* indicates AS Woolf was primary supervisor<br />
MD Theses completed and awarded with subsequent appointments<br />
* Naima Smeulders (1999-2002; cosupervisor Mr DT Wilcox) University of Cambridge MD<br />
awarded 2002: The cell biology of the developing mouse detrusor muscle. 2002 Undertook SpR<br />
training in Paediatric Surgery/Urology.<br />
* Nikesh Thiruchelvam (2001-2003; cosupervisors Mr PM Cuckow, Professor C Fry) University of<br />
London MD awarded 2003: Effects of experimental outflow obstruction on the developing<br />
bladder. 2003 Took up the Wessex Urology SpR Training Programme.<br />
* Marie-Klaire Farrugia (2003-2005; cosupervisors Mr PM Cuckow and Professor C Fry) MD:<br />
Short-term fetal bladder outflow obstruction in the ovine model: bladder morphology, physiology<br />
and in-utero urodynamics. 2005 Joined Paediatric Surgery clinical training programme.<br />
MSc Theses completed and awarded with subsequent appointments<br />
* Rehab Attar (1996-1997) University of London MSc awarded 1997: Cell biology of obstruction of<br />
the fetal sheep kidney. 1997 She returned to Saudi Arabia to finish Surgical training.<br />
* Fabienne Smith (2000-2001) University of London MSc awarded 2001: Antenatal detection of<br />
kidney and lower urinary tract malformations in children with chronic renal failure: a retrospective<br />
study. After, she returned to Paediatric clinical training.<br />
PhD Theses in progress<br />
* Shun Kai Chan (2005-present; cosupervisor Dr PR Riley) PhD: Effects of corticosteroids on<br />
kidney development (being written-up)<br />
Jennifer Huang (2009-present; co-supervisors Dr DA Long and Dr PJ Winyard) Targeting blood<br />
vessels to prevent autosomal recessive polycystic kidney disease.<br />
Shazia Adalat (2009-present; co-supervisors Dr D Bockenhauer and Prof R Kleta) The genetic<br />
basis of human non-syndromic renal tract malformations.<br />
MD Theses in progress<br />
* Larissa Kerecuk (2007-present; co-supervisor Prof PJ Scambler) Exploring the expression and<br />
potential roles of Fras1 and Frem2 in models of kidney diseases affecting the collecting duct<br />
lineage. (being written-up)<br />
MPhil in progress<br />
* Helen M. Stuart (2011-present; co-supervisor Dr W Newman) Understanding genetic causes of<br />
renal tract anomalies.<br />
Non-submitted theses<br />
MR (Shuman) Haq (1997-2001; cosupervisor Dr WG van't Hoff) PhD: Biology of nephropathic<br />
cystinosis.<br />
24
25<br />
9. ACADEMIC SUPERVISION (continued)<br />
Supervised Visiting/Travelling Research Fellows<br />
Berk Burgu (2004-2005; joint supervisor, Mr DT Wilcox). For his research, Dr Burgu was<br />
awarded „Best EUSP Scholar 2005‟ by the European Urological Scholarship Programme<br />
sponsored by the European Association of Urology.<br />
* Michiel Schreuder (2007-present). From the Erasmus MC-Sophia Children‟s Hospital,<br />
Rotterdam, The Netherlands.<br />
Supervised 3 rd Year BSc Projects<br />
* Christopher G Scott (1997) UCL BSc. The effects of retinoic acid on early development of the<br />
mammalian kidney.<br />
* Prital Patel (2004-2005) UCL BSc. The relationship between hypoxia and vascular endothelial<br />
growth factor in the developing embryo..<br />
* Aliyah Madhany (2004-2005) UCL BSc. The expression of sonic hedgehog signaling genes in<br />
human kidney development<br />
25
26<br />
10. TEACHING ACTIVITY<br />
Major meetings organised at the Institute of Child Health<br />
I direct the Continuing Education Programme in Paediatric Nephrology and Urology, an annual<br />
event (which I have directed since 1998) which lasts one week and transmits advances in clinical<br />
and science aspects to clinical trainees and consultants. The current programme is available at<br />
http://www.ich.ucl.ac.uk/education/short_courses/courses/2S_57<br />
In 1994 I initiated a Kidney Development Workshop which has been held annually and brings<br />
together scientists and clinicians interested in normal and abnormal kidney development. These<br />
meetings attract up to 50 attendees who can present work-in-progress. The following Workshops<br />
were held at the Institute of Child Health: 1994, 1995, 1997, 1999; 2005 and 2007.<br />
In 2006, I organised and hosted a Wellcome Trust-sponsored one day symposium called<br />
“Vesicoureteric reflux and the genetics of renal development”.<br />
Teaching and supervision of research staff<br />
Since moving to the Institute of Child Health in 1993, I have encouraged both clinical fellows and<br />
graduate student scientists to work in my laboratory research group. The clinical and science<br />
students who have successfully completed their theses and obtained higher degrees, number<br />
eleven PhDs (M Kolatsi-Joannou, P Towers, PJD Winyard, C Cale, SA Feather, T Johnson, D<br />
Long, L McCarthy, D Jenkins, M Chiu and C Lye), three MD theses (N Smeulders, N<br />
Thiruchelvam and MK Farrugia) and two MSc theses (Drs R Attar and F Smith). Currently, I<br />
supervise one PhD student (S-K Chan) and two MD Res students (D Desai and L Kerecuk).<br />
With regard to basic scientists, three Medical Research Council and three National Kidney<br />
Research Fund/Kidney Research UK studentships have been held by basic scientists in my<br />
research laboratory. One of my postdoctoral research assistants, Dr HT Yuan, was promoted to a<br />
Lecturer at the UCL ICH in 2000 (subsequently moving to Harvard, USA), and another, Dr S<br />
Loughna, was appointed as a Lecturer in Developmental Biology in the University of Nottingham<br />
in 2001. Dr D Long and Dr T Johnson were awarded UCL Bogue Fellowships to further their<br />
research in the USA, with Dr DA Long returning and being awarded a Kidney Research UK<br />
Senior Fellowship.<br />
With regard to the clinical fellows, I have been successful in helping them to write applications for<br />
research, with four Action Research, one Medical Research Council, one National Kidney<br />
Research Fund, and one Royal College of Surgeons (England) clinical training fellowships<br />
obtained. Two of these individuals (Dr PJD Winyard and Dr SA Feather) became Lecturers in<br />
Paediatric Clinical Science at UCL ICH and continued research in the biology and genetics of<br />
kidney malformations; Dr PJD Winyard is currently Head of Learning and Teaching at UCL ICH.<br />
Other teaching activities<br />
I chair Wednesday Lunchtime Clinical Presentations at Great Ormond Street Hospital (2001present),<br />
a teaching forum for clinicians and nurses.<br />
I helped to initiate, and currently chair, Nephrology „Bipartite‟ meetings which provide a forum for<br />
exchange of clinical cases and research from Great Ormond Street Hospital, and local Adult<br />
Nephrology centres including University College and Royal Free Hospitals.<br />
26
27<br />
11. ENABLING ACTIVITY<br />
Institute of Child Health and Great Ormond Street Hospital NHS Trust<br />
1994-present Unit Genetic Manipulation Safety representative<br />
1994-2009 Attend weekly meetings for Nephrology Clinical Unit Senior Staff<br />
1997-2001 Chair weekly meetings for Nephro-Urology Unit Senior Staff<br />
1997-2010 Head of the Academic Nephro-Urology Unit<br />
1997-2000 Attend regular meetings for Heads of Unit in Congenital Anomaly Theme<br />
1997-2009 Member of Research Degrees Committee (2-3 meetings/year)<br />
1998 Working Party on the Chair on Human Genetics<br />
1998-2003 Member of Local Animal Ethical Committee<br />
2001-2008 Chair Clinical Teaching Meetings (weekly) at Great Ormond Street Hospital<br />
2001-2008 Chair joint ICH/GOSH Grand Rounds (monthy)<br />
2002-2003 Library Committee member.<br />
2003-2004 Member of Institute of Child Health Joint Research and Strategy Committee<br />
2003-2009 Chair Nephro-Urology Unit Research and Development monthly meetings<br />
University of Manchester<br />
2010-present Member of the Children‟s Research Committee, Royal Manchester Children‟s<br />
Hospital.<br />
Miscellaneous Other Activity<br />
In 1998 I acted as a spokesperson for an awareness campaign for the National Kidney Research<br />
Fund involving television, radio and newspaper interviews.<br />
I served on the Organising/Scientific committees for the International Workshop on<br />
Developmental Nephrology, held in 2001 and 2004.<br />
From 1998-2002 I acted as the Academic Representative for Training in Paediatric Nephrology in<br />
the Royal College of Paediatric and Child Health Speciality Advisory Committee (CSAC).<br />
27
28<br />
12A. PUBLICATIONS – EDITED BOOKS<br />
Vize PD, Woolf AS, Bard JBL. The Kidney: from normal development to congenital abnormalities.<br />
Elsevier Science/Academic Press, 1-519, 2003.<br />
Chitty L, Woolf AS. Guest Editors. Perinatal renal disease. Seminars in Fetal and Neonatal<br />
Medicine. 13: in press.<br />
12B. PUBLICATIONS – CHAPTERS IN BOOKS<br />
1. Fine LG, Kurtz I, Woolf AS, Danovitch GM, Emmons C, Kujubu DA, Norman JT.<br />
Pathophysiology and nephron adaptation in chronic renal failure. In Diseases of the Kidney Ed.<br />
Schrier and Gottschalk. Little and Brown, Boston, USA. 2703-2742, 1992.<br />
2. White SJ, Masters JRW, Woolf AS. Chapter 4. Renal and bladder epithelial cells. In Handbook<br />
in Practical Animal Cell Biology: Epithelial Cell Culture. Ed Harris A. Cambridge University Press,<br />
Cambridge, UK. 58-78, 1996.<br />
3. Woolf AS. The biology of kidney malformations. In Embryos, Genes and Birth Defects. Ed.<br />
Thorogood P. John Wiley and Sons Ltd, London, UK. 303-327, 1997.<br />
4. Woolf AS. Chapter 1. Developmental anatomy and physiology of the kidney. In Investigation<br />
and Management of Inherited Disorders of the Kidney. Eds. Morgan SH and Grunfeld J-P. <strong>Oxford</strong><br />
University Press, <strong>Oxford</strong>, UK. 3-20, 1998.<br />
5. Woolf AS. Chapter 50. The single kidney. In Pediatric Surgery and Urology: Long-Term<br />
Outcomes. Eds. Stringer MD, Mouriquand PDE, Oldham KT, Howard ER. WB Saunders<br />
Company Ltd, London, UK. 625-631, 1998.<br />
6. Risdon RA, Woolf AS. Chapter 2. Development of the kidney. In Heptinstall's Pathology of the<br />
Kidney. 5th edition. Eds Jennette JC, Olson JL, Schwartz MM, Silva FG. Lippincott-Raven,<br />
Philadelphia-New York, USA. 67-84, 1998.<br />
7. Risdon RA, Woolf AS. Chapter 26. Developmental defects and cystic diseases of the kidney.<br />
In Heptinstall's Pathology of the Kidney. 5th edition. Eds Jennette JC, Olson JL, Schwartz MM,<br />
Silva FG. Lippincott-Raven, Philadelphia-New York, USA. 1149-1206, 1998.<br />
8. Woolf AS. Chapter 1: Embryology of the kidney. In Pediatric Nephrology 4th Edition. Eds<br />
Barratt TM, Avner A, Harmon W. Williams and Wilkins, Baltimore, USA. 1-19, 1999.<br />
9. Woolf AS. Primary vesicoureteric reflux and associated nephropathies. In Horizons in Medicine<br />
11. Ed. Pusey C. Royal College of Physicians of London, UK. 325-333, 1999.<br />
10. Woolf AS. Chapter 15. Genes, urinary tract development and human disease. In Pediatric<br />
Urology. Eds Gearhart JP, Rink RC, Mouriquand PDE. WB Saunders Company. 225-236, 2001.<br />
11. Woolf AS, Yuan HT. Chapter 17. The development of kidney blood vessels. In The Kidney:<br />
from Normal Development to Congenital Disease. Vize PD, Woolf AS, Bard JBL. Elsevier<br />
Science/Academic Press, 251-266, 2003.<br />
28
29<br />
13. Woolf AS. Chapter 28. Congenital kidney diseases: prospects for new therapies. In The<br />
Kidney: from Normal Development to Congenital Disease. Eds Vize PD, Woolf AS, Bard JBL.<br />
Elsevier Science/Academic Press, 487-492, 2003.<br />
12B. PUBLICATIONS – CHAPTERS IN BOOKS (continued)<br />
14. Woolf AS. Anomalies du developpement et mechanisms des malformations du rein et de<br />
l‟appareil urinaire (When kidney development goes wrong: mechanisms of malformations). In<br />
Actualites Nephrologiques Jean Hamburger/Hopital Necker. Medecine-Sciences, Flammarion,<br />
Paris. 23-30, 2003<br />
15. Woolf AS. Kidney and lower urinary tract malformations. In <strong>Oxford</strong> Monographs on Medical<br />
Genetics 48: The Genetics of Renal Disease. Eds Flinter F, Maher E, Saggar-Malik A. <strong>Oxford</strong><br />
University Press, <strong>Oxford</strong>, UK. 89-115, 2003.<br />
16. Woolf AS. Chapter 1: Embryology. In Pediatric Nephrology 5th Edition. Eds Avner ED,<br />
Harmon WE, Niaudet P. Williams and Wilkins, Baltimore, USA. 3-24, 2004.<br />
17. Woolf AS, Jenkins D. Chapter 2. Development of the kidney. In Heptinstall's Pathology of the<br />
Kidney. 6th edition. Eds Jennette JC, Olson JL, Schwartz MM, Silva FG. Lippincott-Raven,<br />
Philadelphia-New York, USA. 71-95, 2006.<br />
18. Woolf AS. Chapter 53. The single kidney. In Pediatric Surgery and Urology: Long-Term<br />
Outcomes. Eds. Stringer MD, Mouriquand PDE, Oldham KT. Cambridge University Press,<br />
Cambridge, UK. 675-682, 2006.<br />
19. Woolf AS, Pitera JE. Chapter 1: Embryology. In Pediatric Nephrology 6th Edition. Eds Avner<br />
ED, Harmon WE, Niaudet P, Yoshikawa N. Springer. 3-30, 2009.<br />
20. Woolf AS. Chapter 12. Genes, urinary tract development and human disease. In Pediatric<br />
Urology. 2 nd Edition. Eds Gearhart JP, Rink RC, Mouriquand PDE. Elsevier, Philadelphia, PA,<br />
US. 172-179, 2010.<br />
21. Stuart HM, Woolf AS. Genetics of renal tract malformations. In Progress in Paediatric<br />
Urology. Clinical Research: Current and Potential Applications. In press.<br />
29
30<br />
12C. PUBLICATIONS – ORIGINAL RESEARCH ARTICLES<br />
1. Boyland E, Woolf AS. Effect of thiocyanate on nitrite estimation and the cleavage of<br />
nitrosamines. IARC Sci Publ 161-171, 1976.<br />
2. Tung KT, Woolf A, Falzon M. Prostatic involvement in Wegeners granulomatosis. Postgrad<br />
Med J 63:53-54, 1987.<br />
3. Woolf AS, Conway G. Systemic lupus erythematosus and primary cerebral lymphoma.<br />
Postgrad Med J 63:569-571, 1987.<br />
4. Rode J, Dillon AP, Cotton PB, Woolf A, O'Riordan JLH. Carcinoid tumour of the stomach and<br />
primary hyperparathyroidism. J Clin Pathol 40:546-551, 1987.<br />
5. Woolf AS, Moult PJA. Plasma levels of atrial natriuretic peptide in hyperthyroidism. Clin<br />
Endocrinol 27:721-725, 1987.<br />
6. Woolf AS, Moult PJA. Plasma levels of atrial natriuretic peptide in hypothyroidism. Brit Med J<br />
296:531, 1988.<br />
7. Woolf AS, Simpson KL, Mansell MA, Moult PJA. The effect of renal transplantation on plasma<br />
levels of atrial natriuretic factor. Nephrol Dial Transplant 2:205-209, 1988.<br />
8. Woolf AS, Street PR, Walmsley K, Cohen SL. Portal vein thrombosis in the nephrotic<br />
syndrome. Nephrol Dial Transplant 4:581-582, 1989.<br />
9. Woolf AS. MD Thesis. Atrial Natriuretic Factor and Chronic Renal Disease. University of<br />
London. 1-290, 1989.<br />
10. Woolf AS, Cohen SL, Hoffbrand BI, Mansell MA, Moult PJA. The effects of low dose<br />
intravenous 99-126 atrial natriuretic peptide infusion in patients with chronic renal failure.<br />
Postgrad Med J 65:362-366, 1989.<br />
11. Woolf AS, Lyon TL, Cohen SL, Hoffbrand B, Moult PJA. Effects of physiological infusion of<br />
atrial natriuretic factor on healthy subjects and patients with nephrotic syndrome. Nephron<br />
54:244-250, 1989.<br />
12. Woolf AS. Does atrial natriuretic factor contribute to the progression of renal disease? Med<br />
Hypotheses 31:261-263, 1990.<br />
13. Woolf AS, Palmer SJ, Snow ML, Fine LG. Creation of a functioning chimeric mammalian<br />
kidney. Kidney Int 38:991-997, 1990.<br />
14. Woolf AS, Hornbruch A, Fine LG. Integration of new embryonic nephrons into the kidney. Am<br />
J Kid Dis 17:611-614, 1991.<br />
15. Woolf AS, Bosch RJ, Fine LG. Gene transfer into the mammalian kidney: microtransplantation<br />
of retrovirus-transduced metanephric tissue. Exp Nephrol 1:41-48, 1993.<br />
16. Bosch RJ, Woolf AS, Fine LG. Gene transfer into the mammalian kidney: direct retrovirus<br />
transduction of regenerating tubular epithelial cells. Exp Nephrol 1:49-54, 1993.<br />
30
31<br />
17. Hardman P, Landels E, Woolf AS, Spooner BS. Transforming growth factor-�1 inhibits<br />
growth and branching morphogenesis in embryonic mouse submandibular and sublingual glands.<br />
Dev Growth Differ 36:567-577, 1994.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
18. Woo DDL, Miao S, Pelayo J, Woolf AS. Taxol inhibits progression of congenital polycystic<br />
kidney disease. Nature 368:750-753, 1994.<br />
19. Barber RD, Woolf AS, Henderson RM. A characterisation of the chloride conductance in<br />
mesangial cells from the H-2K b -tsA58 transgenic mouse. Biochim Biophys Acta 1269:267-274,<br />
1995.<br />
20. Woolf AS, Kolatsi-Joannou M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS,<br />
Noble MD, Gherardi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in<br />
the early development of the metanephros. J Cell Biol 128:171-184, 1995.<br />
21. Kolatsi-Joannou M, Woolf AS, Hardman P, Gordge M, White S, Henderson R. The<br />
hepatocyte growth factor/scatter factor receptor, met, transduces a morphogenetic signal in renal<br />
glomerular fibromuscular mesangial cells. J Cell Sci 108:3703-3714, 1995.<br />
22. Duke V, Winyard PJD, Thorogood PV, Soothill P, Bouloux PMG, Woolf AS. KAL, a gene<br />
mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol<br />
Cell Endocrinol 110:73-79, 1995.<br />
23. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon AR, Woolf AS.<br />
Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49:135-146,<br />
1996.<br />
24. Winyard PJD, Risdon RA, Sams VR, Dressler GR, Woolf AS. The PAX2 transcription factor is<br />
expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J<br />
Clin Invest 98:451-459, 1996.<br />
25. Winyard PJD, Bao Q, Hughes RC, Woolf AS. Epithelial galectin-3 during human<br />
nephrogenesis and childhood cystic diseases. J Am Soc Nephrol 8:1647-1657, 1997.<br />
26. Barber RD, Woolf AS, Henderson RM. Proliferative state affects potassium conductances in<br />
conditionally-immortal renal glomerular mesangial cells. Biochim Biophys Acta 1355:191-203,<br />
1997.<br />
27. Kolatsi-Joannou M, Moore R, Winyard PJD, Woolf AS. Expression of hepatocyte growth<br />
factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis.<br />
Pediatr Res 41:657-665, 1997.<br />
28. Feather SA, Woolf AS, Malcolm S, Donnai D, Winter R. The oral-facial-digital syndrome type<br />
1, a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-22.3.<br />
Hum Mol Genet 6:1163-1167, 1997.<br />
29. Feather SA, Winyard PJD, Dodd S, Woolf AS. Oral-facial-digital syndrome type 1 is another<br />
dominant polycystic kidney disease: clinical, radiological and histopathological features of a new<br />
kindred. Nephrol Dial Transplant 12:1354-1361, 1997.<br />
30. Loughna S, Hardman P, Landels E, Jussila L, Alitalo K, Woolf AS. A molecular and genetic<br />
analysis of renal glomerular capillary development. Angiogenesis 1:84-101, 1997.<br />
31
32<br />
31. Loughna S, Yuan HT, Woolf AS. Effects of oxygen on vascular patterning in Tie1/LacZ<br />
metanephric kidneys in vitro. Biochem Biophys Res Commun 247:361-366, 1998.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
32. Duke V, Quinton R, Gordon I, PMG Bouloux, Woolf AS. Proteinuria, hypertension and chronic<br />
renal failure in X-linked Kallmann's syndrome, a defined genetic cause of solitary functioning<br />
kidney. Nephrol Dial Transplant 13:1998-2003, 1998.<br />
33. Towers PR, Woolf AS, Hardman P. Glial cell line-derived neurotrophic factor stimulates<br />
ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp Nephrol 6:337-<br />
351, 1998.<br />
34. Attar R, Quinn F, Winyard PJD, Mouriquand PDE, Foxall P, Hanson MA, Woolf AS. Shortterm<br />
urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal<br />
sheep kidneys. Am J Pathol 152:1225-1235, 1998.<br />
35. Cale CM, Klein NJ, Morgan G, Woolf AS. Tumour necrosis factor-� inhibits epithelial<br />
differentiation and morphogenesis in the mouse metanephric kidney in vitro. Int J Dev Biol<br />
42:663-674, 1998.<br />
36. Woolf AS. Solitary kidney and bicornuate uterus in mother and child. Nephrol Dial Transplant<br />
14:960-961, 1999.<br />
37. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of<br />
Bardet-Biedl syndrome: results of a population survey. J Med Genet 36:437-446, 1999.<br />
38. Leimeister C, Bach A, Woolf AS, Gessler M. Screen for genes regulated during early kidney<br />
morphogenesis. Dev Genet 24:273-283, 1999.<br />
39. Yuan HT, Suri C, Yancopoulos GD, Woolf AS. Expression of angiopoietin-1, angiopoietin-2<br />
and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol<br />
10:1722-1736, 1999.<br />
40. Cale CM, Winyard PJD, Klein NJ, Woolf AS. Inflammatory mediators in human renal<br />
dysplasia. Nephrol Dial Transplant 15:173-183, 2000.<br />
41. Feather SA, Malcolm S, Woolf AS, Wright V, Blaydon D, Reid CJD, Flinter FA, Proesmans<br />
W, Devriendt K, Carter J, Warwicker P, Goodship THJ, Goodship JA. Primary, non-syndromic<br />
vesicoureteric reflux and its nephropathy is genetically heterogeneous with a locus on<br />
chromosome 1. Am J Hum Genet 66:1420-1425, 2000.<br />
42. Yuan H-T, Suri C, Landon DN, Yancopoulos GD, Woolf AS. Angiopoietin-2 is a site specific<br />
factor in differentiation of mouse renal vasculature. J Am Soc Nephrol 11:1055-1066, 2000.<br />
43. Yuan HT, Yang SP, Woolf AS. Hypoxia upregulates angiopoietin-2, a Tie-2 ligand, in mouse<br />
mesangial cells. Kidney Int 58:1912-1919, 2000.<br />
44. Yang SP, Woolf AS, Yuan HT, Scott RJ, Risdon RA, O‟Hare MJ, Winyard PJD. Potential<br />
biological role of transforming growth factor �1 in human congenital kidney malformations. Am J<br />
Pathol 157:1633-1647, 2000.<br />
32
33<br />
45. Beales PL, Reid HAS, Griffiths M, Maher ER, Flinter FA, Woolf AS. Renal cancers and<br />
malformations in relatives of patients with Bardet-Biedl syndrome. Nephrol Dial Transplant<br />
15:1977-1985, 2000.<br />
46. Andreu N, Escarceller M, Feather S, Devriendt K, Woolf AS, Estivill X, Sumoy L. PALML, a<br />
novel paralemmin-related gene mapping on human chromosome 1p21. Gene 278:33-40, 2001.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
47. Bingham C, Bulman MP, Ellard S, Allen LIS, Lipkin GW, van‟t Hoff WG, Woolf AS, Rizzoni G,<br />
Novelli G, Nicholls AJ, Hattersley AT. Mutations in the hepatocyte nuclear factor-1�<br />
associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 68:219-<br />
224, 2001.<br />
48. Bullock SL, Johnson T, Bao Q, Winyard PJD, RC Hughes, Woolf AS. Galectin-3 modulates<br />
ureteric bud branching in organ culture of the developing mouse kidney. J Am Soc Nephrol<br />
12:515-523, 2001.<br />
49. Ferrante MI, Giorgio G, Feather SA, Bulfone A, Wright V, Ghiani M, Selicorni A, Gammaro L,<br />
Scolari F, Woolf AS, Odent S, Le Marec B, Malcolm S, Winter R, Ballabio A, Franco B.<br />
Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet 68:569-576,<br />
2001.<br />
50. Smellie J, Barratt TM, Chantler C, Gordon I, Prescod NP, Ransley PG, Woolf AS. Medical<br />
versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral<br />
nephropathy: a randomised trial. The Lancet, 357:1329-1333, 2001.<br />
51. Deeb A, Robertson A, MacColl G, Bouloux PM, Gibson M, Winyard PJD, Woolf AS, Moghal<br />
NE, Cheetham TD. Multicystic kidney and X-linked Kallmann‟s syndrome: a new association?<br />
Nephrol Dial Transplant 16:1170-1175, 2001.<br />
52. Coward RJM, Risdon AR, Bingham C, Hattersley AT, Woolf AS. Kidney disease in<br />
hypomelanosis of Ito. Nephrol Dial Transplant 16:1267-1269, 2001.<br />
53. Yang SP, Woolf AS, Quinn F, Winyard PJD. Deregulation of renal transforming growth factor-<br />
�1 after experimental short-term ureteric obstruction in fetal sheep. Am J Pathol 159:109-117,<br />
2001.<br />
54. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, Friedlander G, Terzi F. Proliferation and<br />
remodeling of the peritubular microcirculation after nephron reduction. Association with the<br />
progression of renal lesions. Am J Pathol 159:547-560, 2001.<br />
55. Kolatsi-Joannou M, Li X, Suda T, Yuan HT, Woolf AS. Expression and potential role of<br />
angiopoietins and Tie-2 in early development of the mouse metanephros. Dev Dyn 222:120-126,<br />
2001.<br />
56. Kolatsi-Joannou M, Bingham C, Ellard S, Bulman MP, Allen LIS, Hattersley AT, Woolf AS.<br />
Hepatocyte nuclear factor 1�: a new kindred with renal cysts and diabetes, and gene expression<br />
in normal human development. J Am Soc Nephrol 12:2175-2180, 2001.<br />
57. Long DA, Woolf AS, Suda T, Yuan HT. Increased renal angiopoietin-1 expression in folic<br />
acid-induced nephrotoxicity in mice. J Am Soc Nephrol 12:2721-2731, 2001.<br />
58. Pitera JE, Smith VV, Woolf AS, Milla PJ. Embryonic gut anomalies in a mouse model of<br />
retinoic acid-induced caudal regression syndrome. Delayed gut looping, rudimentary cecum and<br />
anorectal anomalies. Am J Pathol 159:2321-2329, 2001.<br />
33
34<br />
59. Hillman KA, Johnson TM, Winyard PJD, Burnstock G, Unwin RJ, Woolf AS. P2X7 receptors<br />
are expressed during mouse nephrogenesis and in collecting duct cysts of the cpk/cpk mouse.<br />
Exp Nephrol 10:34-42, 2002.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
60. Smeulders N, Woolf AS, Wilcox DT. Smooth muscle differentiation and cell turnover in mouse<br />
detrusor development. J Urol 167:385-390, 2002.<br />
61. Welham SJM, Wade A, Woolf AS. Protein restriction in pregnancy is associated with<br />
increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int<br />
61:1231-1242, 2002.<br />
62. Yuan HT, Tipping PG, Li XZ, Long DA, Woolf AS. Angiopoietin correlates with glomerular<br />
capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int 61:2078-<br />
2089, 2002.<br />
64. Haq MR, Kalatzis V, Gubler M-C, Town MM, van‟t Hoff WG, Antignac C, Woolf AS. Immunolocaization<br />
of cystinosin, the protein defective in cystinosis. J Am Soc Nephrol 13:2046-2051,<br />
2002.<br />
65. Nyirady P, Thiruchelvam N, Fry CH, Godley ML, Winyard PJD, Peebles DM, Woolf AS,<br />
Cuckow PM. Effects of in utero bladder outflow obstruction on fetal sheep detrusor contractility,<br />
compliance and innervation. J Urol 168:1615-1620, 2002.<br />
66. Waller SC, Rees L, Woolf AS, Ellard S, Pearson ER, Hattersley AT, Bingham C. Severe<br />
hyperglycemia after renal transplantation in a pediatric patient with mutation of the hepatocyte<br />
nuclear factor 1� gene. Am J Kidney Dis 40:1325-1330, 2002.<br />
67. Smeulders N, Woolf AS, Wilcox DT. Extracellular matrix protein expression during mouse<br />
detrusor development. J Pediatr Surg 38:1-12, 2003.<br />
68. Romio R, Wright V, Price K, Winyard PJD, Donnai D, Porteous ME, Franco B, Giorgio G,<br />
Malcolm S, Woolf AS, Feather SA. OFD1, the gene mutated in oral-facial-digital syndrome type<br />
1, is expressed in the metanephros and in human embryonic renal mesenchymal cells. J Am Soc<br />
Nephrol 14:680-689, 2003.<br />
69. Gordon I, Barkovics M, Pindoria S, Cole TJ, Woolf AS. Primary vesicoureteric reflux as a<br />
predictor of renal damage in children hospitalized with urinary tract infection: a systematic review<br />
and meta-analysis. J Am Soc Nephrol 14:739-744, 2003.<br />
70. Thiruchelvam N, Nyirady P, Peebles DM, Fry CH, Cuckow PM, Woolf AS. Urinary outflow<br />
obstruction increases apoptosis and degregulates Bcl-2 and Bax expression in the fetal ovine<br />
bladder. Am J Pathol 162:1271-1282, 2003.<br />
71. Thiruchelvam N, Wu C, David A, Woolf AS, Cuckow PM, Fry CH. Neurotransmission and<br />
viscoelasticity in the ovine fetal bladder after in utero bladder outflow obstruction. Am J Physiol<br />
Regul Integr Comp Physiol 284:R1296-R1305, 2003.<br />
72. McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, Smart N, Rutland<br />
P, Prescott N, Hopkins J, Bentley E, Shaw A, Roberts E, Mueller R, Jadeja S, Philip N, Nelson J,<br />
Francannet C, Perez-Aytes A, Megarbane A, Kerr B, Wainwright B, Woolf AS, Winter RM,<br />
34
35<br />
Scambler PJ. Fraser syndrome and mouse blebbed phenotype caused by mutations in<br />
FRAS1/Fras1 encoding a putative extracellular matrix protein. Nature Genet 34:203-208, 2003.<br />
73. Yuan HT, Li XZ, Pitera JE, Long DA, Woolf AS. Peritubular capillary loss following mouse<br />
acute nephrotoxicity correlates with downregulation of vascular endothelial growth factor-A and<br />
hypoxia-inducible factor-1� Am J Pathol 163:2289-2301, 2003.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
74. Hillman KA, Woolf AS, Johnson T, Wade A, Unwin RJ, Winyard PD. The P2X7 ATP<br />
receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun 322:434-<br />
439, 2004.<br />
75. Jiang S, Gitlin J, Deng F, Liang FX, Atala A, Bauer SB, Ehrlich GD, Feather SA, Goldberg JD,<br />
Goodship JA, Goodship THJ, Hermanns M, Jones KE, Malcolm S, Mendelsohn C, Preston RA,<br />
Retnik AB, Schneck FX, Wright V, Ye XY, Woolf AS, Wu XR, Ostrer H, Shapiro E, Yu J, Sun TT.<br />
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for<br />
disease heterogeneity. Kidney Int 66:10-19, 2004.<br />
76. Romio L, Fry AM, Winyard PJD, Malcolm S, Woolf AS, Feather SA. OFD1 is a<br />
centrosomal/basal body protein expressed during mesenchymal-epithelial transition in human<br />
nephrogenesis J Am Soc Nephrol 15:2556-2568, 2004.<br />
77. Pitera JE, Woolf AS, Gale NW, Yancopoulos GD, Yuan HT. Dysmorphogenesis of kidney<br />
cortical peritubular capillaries in angiopoietin-2 deficient mice. Am J Pathol 165:1895-1906, 2004.<br />
78. Tse HK, Leung MB, Woolf AS, Menke AL, Hastie ND, Gosling JA, Pang CP, Shum AS.<br />
Implication of Wt1 in the pathogenesis of nephrogenic failure in a mouse model of retinoic acidinduced<br />
caudal regression syndrome. Am J Pathol 166:1295-1307, 2005.<br />
79. Jadeja S, Smyth I Pitera JE, Taylor MS, van Haelst M, Bentley E, McGregor L, Hopkins J,<br />
Chalepakis G, Philip N, Perez-Aytes A, Watt FM, Darling SM, Jackson I, Woolf AS, Scambler<br />
PJ. Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs.<br />
Nature Genet 37:520-525, 2005.<br />
80. Welham SJM, Riley PR, Wade A, Hubank M, Woolf AS. Maternal diet programs embryonic<br />
kidney gene expression. Physiol Genomics 22:48-56, 2005.<br />
81. Jenkins D, Bitner-Glindzicz M, Malcolm S, Allison J, Hu CC, Winyard PJ, Gullett AM, Thomas<br />
DF, Belk RA, Feather SA, Sun TT, Woolf AS. De novo Uroplakin IIIa mutations cause renal<br />
adysplasia leading to severe kidney failure. J Am Soc Nephrol 16:2141-2149, 2005.<br />
82. Burgu B, McCarthy LS, Long DA, Shah V, Wilcox DT, Woolf AS. Vascular endothelial growth<br />
factor stimulates embryonic urinary bladder development in organ culture. BJU Int 98:217-226,<br />
2006.<br />
83. Farrugia MK, Long DA, Godley ML, Peebles DM, Fry CH, Cuckow PM, Woolf AS.<br />
Experimental short-term fetal bladder outflow obstruction. I. Morphology and cell biology<br />
associated with urinary flow impairment. J Pediatr Urol 2:243-253, 2006.<br />
84. Farrugia MK, Godley ML, Woolf AS, Peebles DM, Cuckow PM, Fry CH. Experimental shortterm<br />
fetal bladder outflow obstruction. II. Compliance and contractility associated with urinary<br />
flow impairment. J Pediatr Urol 2:254-260, 2006.<br />
35
36<br />
85. Long DA, Mu W, Price KL, Roncal C, Schreiner GF, Woolf AS, Johnson RJ. Vascular<br />
endothelial growth factor administration does not improve microvascular disease in the saltdependent<br />
phase of post-angiotensin II hypertension. Am J Physiol Renal Physiol 291:F1298-<br />
F1254, 2006.<br />
86. Jenkins D, Bitner-Glindzicz M, Malcolm S, Allison J, de Bruyn R, Thomas DFM, Belk RA,<br />
Feather SA, Bingham C, Southgate J, Woolf AS. Mutation analyses of Uroplakin II in children<br />
with renal tract malformations. Nephrol Dial Transplant 21:3415-3421, 2006.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
87. Chiu MG, Johnson TM, Woolf AS, Dahm-Vicker EM, Long DA, Guay-Woodford L, Hillman<br />
KA, Bawumia S, Venner K, Hughes RC, Poirier F, Winyard PJ. Galectin-3 associates with the<br />
primary cilium and modulates cyst growth in congenital polycystic kidney disease. Am J<br />
Pathology 169:1925-1938, 2006.<br />
88. Kerecuk L, Sajoo A, McGregor L, Berg J, Haq MR, Sebire NJ, Bingham C, Edghill EL, Ellard<br />
S, Taylor J, Rigden S, Flinter FA, Woolf AS. Autosomal dominant inheritance of non-syndromic<br />
renal hypoplasia and dysplasia: dramatic variation in clinical severity in a single kindred. Nephrol<br />
Dial Transplant 22:259-263, 2007.<br />
89. Wu C, Thiruchelvam N, Sui G, Woolf AS, Cuckow P, Fry CH. Ca (2+) regulation in detrusor<br />
smooth muscle from ovine fetal bladder after in utero bladder outflow obstruction. J Urol<br />
177:776-780, 2007.<br />
90. Price KL, Long DA, Jina N, Liapis H, Hubank M, Woolf AS, Winyard PJ. Microarray<br />
interrogation of human metanephric mesenchymal cells highlights potentially important<br />
molecules in vivo. Physiol Genomics 23:193-202, 2007.<br />
91. Jenkins D, Bitner-Glindzicz M, Thomasson L, Malcolm S, Warne SA, Feather SA, Flanagan<br />
SE, Ellard S, Bingham C, Santos L, Zinn A, Henkemeyer M, Baker LA, Wilcox DT, Woolf AS.<br />
Mutational analyses of UPIIIA, SHH, EFNB2 and HNF1� in persistent cloaca and associated<br />
kidney malformations. J Pediatr Urol 3:2-9, 2007.<br />
92. Lu W, van Eerde AM, Fan X, Quintero-Rivera F, Kulkarni S, Ferguson H, Kim HG, Fan Y, Xi<br />
J, Li QG, Sanlaville D, Andrews W, Sundaresan V, Bi W, Yan J, Giltay JC, Wijmenga C, de<br />
Jong TP, Feather SA, Woolf AS, Rao Y, Lupski JR, Eccles MR, Quade BJ, Gusella JF, Morton<br />
CC, Maas RL. Disruption of ROBO2 is associated with congenital anomalies of kidney and<br />
urinary tract and confers risk of vesicoureteric reflux. Am J Hum Genet 80:616-632, 2007.<br />
93. Burgu B, Medina Ortiz WE, Pitera JE, Woolf AS, Wilcox DT. Vascular endothelial growth<br />
factor mediates hypoxic-stimulated embryonic urinary bladder growth in organ culture. J Urol<br />
177:1552-1557, 2007.<br />
94. Farrugia MK, Woolf AS, Fry CH, Peebles DM, Cuckow PM, Godley ML. Radiotelemetered<br />
urodynamics of obstructed ovine fetal bladders: correlations with ex-vivo cystometry and renal<br />
histopathology. BJU Int 99:1517-1522, 2007.<br />
95. Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku CH, Woolf AS, Bilous R, Viberti G,<br />
Gnudi L. Podocyte-specific, induced overexpression of angiopoietin-2 causes proteinuria and<br />
apoptosis of glomerular endothelia. J Am Soc Nephrol 18:2320-2329, 2007.<br />
96. Yuan HT, Venkatesha S, Chan B, Deutch U, Mammota T, Sukhatme VP, Woolf AS,<br />
Karumanchi SA. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated<br />
intracellular signaling and cell survival. FASEB J 21:3171-83, 2007.<br />
36
37<br />
97. Jenkins D, Winyard PJD, Woolf AS. Immunohistochemical analysis of sonic hedgehog<br />
signalling in normal human urinary tract development. J Anat 211:620-629, 2007.<br />
98. Long DA, Price KL, Ioffe E, Gannon CM, Gnudi L, White KE, Yancopoulos GD, Rudge JS,<br />
Woolf AS. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acidinduced<br />
acute renal injury. Kidney Int 74: 300-309, 2008.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
99. Caubit X, Lye CM, Martin E, Core N, Long DA, Vola C, Jenkins D, Garratt AN, Skaer H,<br />
*Woolf AS, *Fasano L (*joint communicating authors). Teashirt 3 is necessary for ureteral<br />
smooth muscle differentiation downstream of SHH and BMP4. Development 135:3301-3310,<br />
2008.<br />
100. Pitera JE, Scambler PJ, Woolf AS. Fras1, a basement membrane-associated protein<br />
mutated in Fraser syndrome, mediates both the initiation of the mammalian kidney and the<br />
integrity of renal glomeruli. Hum Mol Genet 17:3953-3964, 2008.<br />
101. Ferrante MI, Romio L, Castro S, Collins JE, Goulding DA, Stemple DL, Woolf AS, Wilson<br />
SW. Convergent extension movements and ciliary function are mediated by ofd1, a zebrafish<br />
orthologue of the human oral-facial-digital type 1 syndrome gene. Hum Mol Genet 18:289-303,<br />
2009.<br />
102. Pastorelli L, Wells S, Fray M, Smith A, Hough T, Harfe BD, McManus MT, Smith L, Woolf<br />
AS, Cheeseman M, Greenfield A. Genetic analyses reveal a requirement for Dicer1 in the<br />
mouse urogenital tract. Mamm Genome 20:140-151, 2009.<br />
103. Price KL, Woolf AS, Long DA. Unravelling the genetic landscape of urinary bladder<br />
development in mice. J Urol 181:2366-2374. 2009.<br />
104. Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC,<br />
Ledermann SE, Rees L, van‟t Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick<br />
J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel G, Ellard S,<br />
Bockenhauer D. Hepatocyte Nuclear Factor 1B mutations associate with hypomagnesemia and<br />
renal magnesium wasting. J Am Soc Nephrol 20:1123-1131, 2009.<br />
105. Jenkins D, Caubit X, Dimovski A, Matevska N, Lye CM, Cabuk F, Gucev Z, Tasic V,<br />
Fasano L, Woolf AS. Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction<br />
obstruction. Nephrol Dial Transplant 25:54-60, 2010.<br />
106. Cordell HJ, Darlay R, Charoen P, Stewart A, Gullett AM, Lambert HJ, The UK VUR Study<br />
Group, Malcolm S, Feather SA, Goodship THJ, Woolf AS, Kenda RB, Goodship JA. Wholegenome<br />
linkage and association scan in primary, non-syndromic vesicoureteric reflux. J Am Soc<br />
Nephrol 21:113-123; 2010.<br />
107. Chan S-K, Riley PR, Price KL, McElduff F, Winyard PJ, Welham SJ, Woolf AS, Long DA.<br />
Corticosteroid-induced kidney dysmorphogenesis is associated with deregulated expression of<br />
known cystogenic molecules, as well as indian hedgehog. Am J Physiol Renal Physiol<br />
289:F346-F356, 2010.<br />
108. Daly SB, Urquhart JE, Hilton E, McKenzie EA, Kammerer RA, Lewis M, Kerr B, Stuart H,<br />
Donnai D, Long DA, Burgu B, Aydogdu O, Derbent M, Garcia-Minaur S, Reardon W, Gener B,<br />
Shalev S, Smith R, Woolf AS, Black GC, Newman WG. Mutations in HPSE2 cause urofacial<br />
syndrome. Am J Hum Genet 11:963-969, 2010.<br />
37
38<br />
109. Mekahli D, Woolf AS, Bockenhauer D. Similar renal outcomes in children with ADPKD<br />
diagnosed by screening or presenting with symptoms. Pediatr Nephrol 11:2275-2282, 2010.<br />
110. Yates LY, Papakrivopoulou J, Long DA, Goggolidou P, Connolly JO, Woolf AS, Dean CH.<br />
The planar cell polarity gene Vangl2 is required for mammalian kidney branching<br />
morphogenesis and glomerular maturation. Hum Mol Genet 19:4663-4676, 2010.<br />
12C. PUBLICATIONS - ORIGINAL RESEARCH ARTICLES (continued)<br />
111. Lopes CAM, Prosser SL, Romio L, Hirst RA, O'Callaghan C, Woolf AS, Fry AM. Centriolar<br />
satellites are assembly points for proteins implicated in human ciliopathies including oral-facialdigital<br />
syndrome 1. J Cell Sci 124:600-612, 2011.<br />
112. Lambert HJ, Stewart A, Gullett AM, Cordell HJ, Malcolm S, Feather SA, Goodship JA,<br />
Goodship THJ, Woolf AS; on behalf of the UK VUR Study Group. Primary, non-syndromic<br />
vesicoureteric reflux and nephropathy in sibling pairs: a United Kingdom cohort for a DNA bank.<br />
Clin J Am Soc Nephrol 6:760-766, 2011.<br />
113. Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2<br />
mutations. Marks SD, Gullett AM, Brennan E, Tullus K, Jaureguiberry G, Klootwijk E, Stanescu<br />
HC, Kleta R, Woolf AS. Pediatr Nephrol epub ahead of print DOI: 10.1007/s00467-011-1891-0<br />
12D. PUBLICATIONS - RESEARCH LETTERS<br />
1. Woolf AS, Moult PJA, Sutters M, Mansell MA. Physiological release of atrial natriuretic peptide<br />
in a heart transplant recipient. Lancet 2:213, 1987.<br />
2. Withers DJ, Woolf AS, Kingswood JC, Tsang WN, Mansell MA. Encephalopathy in patient<br />
taking aluminium-containing agents, including sucralfate. Lancet 2:674, 1989.<br />
3. Oram RA, Edghill EL, Woolf AS, Hennekam RC, Ellard S, Hattersley AT, Bingham C. RET<br />
gene mutations are not a common cause of congenital solitary functioning kidney in adults. NDT<br />
Plus 2:183-184, 2009.<br />
38
39<br />
12E. PUBLICATIONS – REVIEWS, TEACHING ARTICLES AND EDITORIALS<br />
1. Woolf AS. Atrial natriuretic peptide and renal disease. Nephrol Dial Transplant 4:1008-1015,<br />
1989.<br />
2. Woolf AS, Fine LG. Retarding the progression of renal diseases. J Nephrol 4:255-267, 1991.<br />
3. Woolf AS, Fine LG. Do glomerular hemodynamic adaptations influence the progression of<br />
human renal disease? Pediatr Nephrol 5:88-93, 1991.<br />
4. Fine LG, Woolf AS, Gallego C. Of rats and men: the need for more convincing studies on<br />
progression of renal diseases. Am J Kidney Dis 18:258-260, 1991.<br />
5. Woolf AS, Bosch RJ, Fine LG. Growth factors in the pathogenesis of renovascular<br />
complications of diabetes mellitus. J Hypertens 10:S11-S16, 1992.<br />
6. Woolf AS, Frischauf A-M, Shaw DG, McCartney SA, Clarkson P. Autosomal dominant<br />
polycystic kidney disease. Lancet 339:1146-1149, 1992.<br />
7. Bard JBD, Woolf AS. Nephrogenesis and the development of renal disease. Nephrol Dial<br />
Transplant 7:563-572, 1992.<br />
8. Prichard BNC, Owens CWI, Woolf AS. Adverse reations to diuretics. Eur Heart J 13:suppl<br />
G96-103, 1993.<br />
9. Woolf AS, Fine LG. Genetically engineered kidneys. Pediatr Nephrol 7:605-608, 1993.<br />
10. Woolf AS, Bosch RJ, Fine LG. Gene transfer into the mammalian kidney. Kidney Int 43:S116-<br />
S119, 1993.<br />
11. Hardman P, Kolatsi M, Winyard PJD, Towers PR, Woolf AS. Branching out with the ureteric<br />
bud. Exp Nephrol 2:211-219, 1994.<br />
12. Woolf AS. Cures for polycystic kidney diseases? Nephrol Dial Transplant 9:1361-1362, 1994.<br />
13. Woolf AS, Winyard PJD. Unravelling the pathogenesis of cystic kidney diseases. Arch Dis<br />
Child 72:103-105, 1995.<br />
14. Woolf AS. Clinical impact and biological basis of kidney malformations. Sem Nephrol 15:361-<br />
372,1995.<br />
15. Loughna S, Landels EC, Woolf AS. Growth factor control of developing kidney endothelial<br />
cells. Exp Nephrol 4:112-118, 1996.<br />
16. Feather SA, Woolf AS, Gordon I, Risdon RA, Verrier-Jones K. Vesicoureteric reflux – all in<br />
the genes? Lancet 348:725-728, 1996.<br />
17. Woolf AS. Genetic manipulation of the embryonic kidney. Exp Nephrol 5:152-156, 1997.<br />
39
40<br />
18. Woolf AS, Cale CM. Roles of growth factors in renal development. Curr Opin Nephrol<br />
Hypertens 6:10-14, 1997.<br />
19. Woolf AS. Molecular bases of human kidney malformations. Pediatr Nephrol 11:373-376,<br />
1997.<br />
12E. PUBLICATIONS – REVIEWS, TEACHING ARTICLES AND EDITORIALS (continued)<br />
20. Woolf AS. Multiple causes of human renal malformations. Arch Dis Child 77:471-473, 1997.<br />
21. Woolf AS. Molecular control of nephrogenesis and the pathogenesis of kidney malformations.<br />
Brit J Urol 81 (suppl 2):1-7, 1998.<br />
22. Woolf AS, Winyard PJD. Advances in the cell biology and genetics of human kidney<br />
malformations. J Am Soc Nephrol 9:1114-125, 1998.<br />
23. Woolf AS, Loughna S. Origin of glomerular capillaries – is the verdict in? Exp Nephrol 6:17-<br />
21, 1998.<br />
24. Woolf AS. Emerging roles of obstruction and mutations in renal malformations. Pediatr<br />
Nephrol 12:690-694, 1998.<br />
25. Dressler GR, Woolf AS. PAX2 in development and renal disease. Int J Dev Biol 43:463-468,<br />
1999.<br />
26. Woolf AS, Beales PL, Feather SA. Human malformation syndromes: lessons in kidney<br />
differentiation. Adv Nephrol Necker Hosp 29:329-339, 1999.<br />
27. Woolf AS, Winyard PJD. Gene expression and cell turnover in human renal dysplasia. Histol<br />
Histopathol 15:159-166, 2000.<br />
28. Woolf AS. Diabetes, genes and kidney development. Kidney Int 57:1202-1203, 2000.<br />
29. Woolf AS. A molecular and genetic view on human kidney and urinary tract malformations.<br />
Kidney Int 58:500-512, 2000.<br />
30. Woolf AS. The life of the human kidney before birth: its secrets unfold. Pediatr Res 49:8-10,<br />
2001.<br />
31. Woolf AS, Yuan HT. Angiopoietin growth factors and Tie receptor tyrosine kinases in renal<br />
vascular development. Pediatr Nephrol 16:177-184, 2001.<br />
32. Woolf AS, Thiruchelvam N. Congenital obstructive uropathy – its origin and contribution to<br />
end-stage renal failure in children. Adv Ren Replace Ther 8:157-163, 2001.<br />
33. Woolf AS, Winyard PJD. Molecular mechanisms of human embryogenesis: developmental<br />
pathogenesis of renal tract malformations. Pediatr Dev Pathol 8:108-129, 2002.<br />
34. Woolf AS, Bingham C, Feather SA. Recent insights into kidney diseases associated with<br />
glomerular cysts. Pediatr Nephrol 17:229-235, 2002.<br />
35. Woolf AS, Welham SJM. Cell turnover in normal and abnormal kidney development. Nephrol<br />
Dial Transplant 17 (Suppl 9):2-4, 2002.<br />
40
41<br />
36. Woolf AS. Congenital obstructive nephropathy gets complicated. Kidney Int 63:761-763,<br />
2003.<br />
37. Welham SJM, Woolf AS. Organ culture of intact metanephric kidneys. Methods Mol Med<br />
86:169-177, 2003.<br />
12E. PUBLICATIONS – REVIEWS, TEACHING ARTICLES AND EDITORIALS (continued)<br />
38. Woolf AS, Price K, Scambler PJ, Winyard PJD. Evolving concepts in human renal dysplasia.<br />
J Am Soc Nephrol 15:998-1007, 2004.<br />
39. Woolf AS. Do kidney tubules serve an angiogenic soup? Kidney Int 66:862-863, 2004.<br />
40. Woolf AS, Wilcox DT. Understanding primary vesicoureteric reflux and associated<br />
nephropathies. Curr Paediatr 14:563-567, 2004.<br />
41. Woolf AS. Molecular and genetic analyses of renal capillary development: studying the<br />
angiopoietin/Tie axis. Kidney Int 68:1968, 2005.<br />
42. Woolf AS. Unilateral multicystic dysplastic kidney. Kidney Int 69:190-193, 2006.<br />
43. Woolf AS. Renal hypoplasia and dysplasia: starting to put the jigsaw together. J Am Soc<br />
Nephrol 17: 2647-2649, 2006.<br />
44. Woolf AS, Hillman KA. Unilateral renal agenesis and the congenital solitary functioning<br />
kidney: developmental, genetic and clinical perspectives. BJU Int 99:17-21, 2007.<br />
45. Jenkins D, Woolf AS. Uroplakins: new molecular players in the biology of urinary tract<br />
malformations. Kidney Int 71:195-200, 2007.<br />
46. Woolf AS. Perspectives on human perinatal renal tract disease. Semin Fetal Neonatal Med<br />
13:196-201, 2008.<br />
47. Kerecuk L, Schreuder MF, Woolf AS. Human renal tract malformations: perspectives for<br />
Nephrologists. Nat Clin Pract Nephrol 4:312-325, 2008.<br />
48. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J<br />
Am Soc Nephrol 20:239-244, 2009.<br />
49. Woolf AS. Angiopoietins: vascular growth factors looking for roles in glomeruli. Curr Opin<br />
Nephrol Hypertens 19:20-25, 2010.<br />
49. Lye CM, Fasano L, Woolf AS. Ureter myogenesis: putting Teashirt into context. J Am Soc<br />
Nephrol 21:24-30, 2010.<br />
50. Farrugia MK, Woolf AS. Congenital urinary bladder outlet obstruction. Fetal and Maternal<br />
Medicine Review 21:155–173, 2010.<br />
51. Adalat S, Bockenhauer D, Ledermann SE, Hennekam RC, Woolf AS. Renal malformations<br />
associated with mutations of developmental genes: messages from the clinic. Pediatr Nephrol<br />
11:2242-2255, 2010.<br />
52. Woolf AS. Environmental influences on renal tract development: a focus on maternal diet and<br />
the glucocorticoid hypothesis. Klin Padiatr Suppl1:S10-S17, 2011.<br />
41
42<br />
42